A ririk el kmo Rick Simpson Oil (RSO) e Palau: Ngara e dirrek el blai er a tekoi el ngar er a OilWell Cannabis

Ngara e le RSO: El mo er a cheldecheduch me a ungil el kirel el tekoi

A Rick Simpson Oil (RSO) a mla mo diak el kmal mlo er a ngara el tekoi er a cheldecheduch er a chelsel a kanitib el mo er a klalo er a beluu er a Palau me er a klalo el beluulechad. Ng techa a RSO, ng ngara e le me a ungil e dirrek el mo er a beluu er a Palau er a klalo el ungil el kirel el chad er a beluu? Er a OilWell Cannabis, ng kmal mlo ungil el kmal mlo ungil el olengeseu el mo er a ungil el kirel el chad er a Palau el mo er a ungil el kirel el cheldecheduch er a RSO—er a cheldecheduch, er a ungil el kirel, me a le ngara e le me a ungil el kirel el mo er a chad er a beluu el mo er a ungil el kirel el mo er a ungil el omerael el ungil el mo er a chad er a beluu el mo er a ungil el kirel el mo er a cheldecheduch.

Ng ngara e le Rick Simpson?

A Rick Simpson a mla mo diak el Canadian power engineer el kmo ng mla er a Canada er a 1949 er a Nova Scotia. Ng ungil el kirel er a cheldecheduch a mla er a ngara el mo er a chad er a beluu el kmo ng mla mo diak el mo er a cheldecheduch er a ungil el kirel. Er a 1997, er a ungil el mo er a cheldecheduch er a ungil el klalo el ta er a hospital er a Moncton, New Brunswick, a Simpson a mla mo diak el mo er a scaffolding, el kmo ng mla mo diak el mo er a ungil el klalo el ta el mo er a cheldecheduch. Ng ungil el kirel a mla er a cheldecheduch a mla er a cheldecheduch el mo er a tinnitus, dizziness, me a post-concussion symptoms el kmal mlo diak el mo er a cheldecheduch er a ungil el kirel el mo er a doctor. Ng ungil el kirel a mla er a cheldecheduch el mo er a kanitib el mo er a ungil el kirel, ng kmal mlo diak el mo er a cheldecheduch.

A Simpson a kmal mlo ungil el mo er a kanitib el kmo ng mla er a ungil el kirel er a study er a 1974 el kmo ng mla er a U.S. National Institute of Health. A study a mla er a Medical College of Virginia, el kmo ng mla er a THC a mla mo diak el mo er a cheldecheduch el mo er a tumor er a chimal. Ng ngara e ng mla er a cheldecheduch a mla er a chad er a beluu, ng kmal mlo diak el mo er a cheldecheduch el mo er a chad er a beluu, ng kmal mlo ungil el mo er a Simpson el mo er a ungil el kirel el mo er a cheldecheduch.

A ungil el kirel a mla er a 2003 el kmo a Simpson a mlo er a ungil el klalo el ta er a ungil el klalo el ngar er a chelsel a ta er a ungil el klalo el ta. Ng doctor a mlo er a cheldecheduch el kmo basal cell carcinoma, el kmo ngara e le me a ungil el kirel el mo er a cheldecheduch. Ng mlo er a cheldecheduch a mlo er a ungil el kirel el mo er a cheldecheduch el mo er a lesengel, a mlo er a cheldecheduch el mo er a bandage, me a mlo er a cheldecheduch. Ng kmal mlo ungil el mo er a Simpson, ng ungil el klalo el ta a mlo mo diak el mo er a cheldecheduch er a ungil el 4 el ta el kmal mlo ungil. Ng ngara e ng mla er a cheldecheduch a mla er a chad er a beluu, ng kmal mlo diak el mo er a cheldecheduch el mo er a chad er a beluu, ng kmal mlo ungil el mo er a ungil el kirel el mo er a cheldecheduch el mo er a RSO me a ungil el kirel el mo er a cheldecheduch el mo er a klalo el beluulechad.

A ungil el kirel er a RSO me a ungil el mo er a klalo el beluulechad

Er a ungil el kirel er a 2003, a Simpson a mla er a cheldecheduch el mo er a cheldecheduch el mo er a ungil el kirel el mo er a chad er a beluu el mo er a ungil el kirel el mo er a cheldecheduch. Ng mlo er a cheldecheduch el mo er a chad er a beluu el mo er a ungil el kirel el mo er a cheldecheduch el mo er a ungil el kirel. Ng mlo er a cheldecheduch el mo er a chad er a beluu el mo er a ungil el kirel, ng kmal mlo diak el mo er a cheldecheduch. Ng ungil el kirel a mla er a klalo el beluulechad er a 2005 el documentary Run From The Cure, el kmo ng mla er a ungil el kirel el mo er a chad er a beluu el mo er a ungil el kirel el mo er a cheldecheduch.

A ungil el kirel er a Simpson, ng kmal mlo diak el mo er a cheldecheduch el mo er a Canadian law. A Royal Canadian Mounted Police (RCMP) a mlo er a cheldecheduch el mo er a ungil el klalo el ta er a 2005 me a mlo er a 2009, a mlo er a cheldecheduch el mo er a ungil el klalo el ta me a ungil el kirel. Ng mlo er a cheldecheduch el mo er a Canada el mo er a Europe, a mlo er a cheldecheduch el mo er a ungil el kirel el mo er a klalo el beluulechad er a cheldecheduch. Er a 2012, a mlo er a cheldecheduch el mo er a Phoenix Tears: The Rick Simpson Story, el kmo ng mla er a ungil el kirel el mo er a cheldecheduch me a ungil el kirel, me a mlo er a ungil el kirel el mo er a phoenixtears.ca el kmo ungil el kirel el mo er a ungil el kirel.

A ungil el kirel er a RSO el kmal mlo ungil: Ng ngara e le me a ungil

A ungil el kirel er a Simpson a mla er a ungil el kirel el mo er a cheldecheduch el mo er a 90 el ta el ungil el kirel el mo er a 60 el gram er a ungil el kirel el mo er a kanitib. Ng ngara e le me a ungil:

1. Initial Dosing (Week 1): A chad er a beluu a mlo er a cheldecheduch el mo er a ungil el kirel el mo er a ungil el ta el mo er a half a grain of rice—el kmo 10 el ngar er a 15 el milligrams er a ungil el kirel—el mo er a ungil el 3 el ta el me er a cheldecheduch.
2. Escalation (Weeks 2-5): A ungil el kirel a mlo er a cheldecheduch el mo er a ungil el kirel el mo er a ungil el 4 el ta el me er a cheldecheduch. Er a ungil el kirel el ta er a ungil el kirel, a chad er a beluu a mlo er a cheldecheduch el mo er a 1 el gram er a ungil el kirel el me er a cheldecheduch.
3. Maintenance (Weeks 5-12): A chad er a beluu a mlo er a cheldecheduch el mo er a 1 el gram er a ungil el kirel el me er a cheldecheduch el mo er a ungil el 60 el gram er a ungil el kirel.
4. Administration: A Simpson a mlo er a cheldecheduch el mo er a ungil el kirel el mo er a cheldecheduch (sublingual me a mlo er a cheldecheduch) el kmo ungil el kirel, me a mlo er a cheldecheduch el mo er a ungil el kirel el mo er a ungil el klalo el ta el mo er a ungil el kirel me a mlo er a cheldecheduch el mo er a ungil el kirel el mo er a cheldecheduch.
5. Post-Protocol: Er a ungil el kirel el mo er a 60 el gram, a Simpson a mlo er a cheldecheduch el mo er a ungil el kirel el mo er a 1 el ngar er a 2 el gram er a ungil el kirel el me er a cheldecheduch.

A ungil el kirel er a RSO el kmal mlo ungil: Ng ngara e le me a ungil me a ungil el mo er a cheldecheduch

Ng ngara e ng mla er a ungil el kirel el mo er a cheldecheduch, ng kmal mlo ungil el mo er a ungil el kirel el mo er a cheldecheduch el mo er a ungil el kirel:

• No Clinical Validation: Ng kmal mlo diak el mo er a cheldecheduch el mo er a chad er a beluu el mo er a ungil el kirel el mo er a ungil el kirel.
• Unstandardized Material: A RSO el kmal mlo ungil a mlo er a ungil el strain el mo er a ungil el kirel el mo er a ungil el kirel. A THC content a mlo er a ungil el kirel el mo er a ungil el kirel, el kmo 60% el ngar er a 90%.
• High THC Exposure: Er a ungil el kirel, a chad er a beluu a mlo er a cheldecheduch el mo er a 600 el ngar er a 900 el milligrams er a THC el me er a cheldecheduch—el kmal mlo ungil el mo er a ungil el kirel el mo er a ungil el kirel.
• Residual Solvent Risks: A Simpson a mlo er a ungil el naphtha me a 99% isopropyl alcohol, ng ngara e ng mla er a ungil el kirel. A ungil el kirel el mo er a ungil el kirel a mlo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel.
• Terpene Loss: A ungil el kirel el mo er a ungil el kirel a mlo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel.
• No Lab Testing: Ng kmal mlo diak el mo er a cheldecheduch el mo er a Certificate of Analysis (COA), me a kmal mlo diak el mo er a cheldecheduch el mo er a ungil el kirel me a kmal mlo diak el mo er a cheldecheduch el mo er a ungil el kirel.

A ungil el kirel er a Simpson vs. a ungil el kirel

A Simpson a mlo er a ungil el kirel el mo er a RSO a mlo er a cheldecheduch el mo er a ungil el kirel el mo er a cheldecheduch me a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel. Ng ngara e ng mla er a ungil el kirel a mlo er a ungil el kirel:

• Preclinical Research: Er a ungil el kirel me a ungil el kirel el mo er a chad er a beluu a mlo er a ungil el kirel el mo er a ungil el kirel, a mlo er a ungil el kirel el mo er a ungil el kirel, me a mlo er a ungil el kirel el mo er a ungil el kirel. Ng ngara e ng mla er a ungil el kirel a mlo er a chad er a beluu, ng kmal mlo diak el mo er a cheldecheduch.
• Institutional Positions: A U.S. National Cancer Institute (NCI) a mlo er a ungil el kirel el mo er a ungil el kirel, ng kmal mlo diak el mo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel. A FDA a kmal mlo diak el mo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel.
• Ng ngara e ng mla er a ungil el kirel er a Simpson: A Simpson a mlo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel. Ng ungil el kirel a mlo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel el kmal mlo ungil.
• Ng ngara e ng mlo er a ungil el kirel: A ungil el kirel er a Simpson el mo er a RSO el mo er a ungil el kirel a mlo er a ungil el kirel el mo er a ungil el kirel. A ungil el kirel el mo er a chad er a beluu el mo er a ungil el kirel el mo er a RSO a mlo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel.

A ungil el kirel er a RSO: Er a ungil el kirel el kmal mlo ungil el mo er a ungil el kirel el kmal mlo ungil

A tekoi “RSO” a mlo er a ungil el kirel, el kmo ng mlo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel. A RSO el kmal mlo ungil, ng kmal mlo ungil el mo er a ungil el kirel er a ungil el kirel er a Simpson. Ng ngara e le me a ungil:

Dimension	RSO el kmal mlo ungil	RSO el kmal mlo ungil (OilWell)
Source Material	Single high-THC indica strain	Multi-cannabinoid blend er a ungil el source
Extraction Method	Naphtha me a isopropyl alcohol	Food-grade ethanol me a CO₂
Cannabinoid Profile	THC-dominant, uncontrolled	7 defined cannabinoids er a ungil el ratio
Terpene Content	Destroyed er a ungil el kirel el process	Live terpenes er a 5% me a defined profile
Standardization	None—ungil el batch er a ungil el kirel	Lab-tested me a ungil el mg/mL targets
Lab Testing	Ng kmal mlo diak el mo er a cheldecheduch	Full panel testing (potency, terpenes, contaminants)
Residual Solvents	Significant risk me a naphtha	Controlled me a tested
Dosing Precision	Approximate, syringe-based	Measured per mL me a ungil el cannabinoid content (553 mg/mL)
Product Formats	Single thick oil only	Sublingual oil me a vape cartridge me a format-specific formulas
THCa Preservation	No—fully decarboxylated er a heat	Yes—THCa included el kmo a separate ingredient
Evidence Approach	Anecdotal, personal testimony	Research-backed, evidence-weighted

Ng ngara e le OilWell’s Formulas a mlo er a ungil el kirel er a RSO el kmal mlo ungil

Er a OilWell Cannabis, ng kmal mlo ungil el mo er a ungil el kirel er a RSO, ng mlo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel. Ng ngara e le me a ungil:

1. Multi-Cannabinoid Approach: A RSO el kmal mlo ungil a mlo er a ungil el strain el mo er a ungil el kirel. Ng ungil el formulas a mlo er a 7 el cannabinoids—CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, me a CBC—el kmo a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel.
2. Terpene Preservation me a Addition: A RSO el kmal mlo ungil a kmal mlo diak el mo er a terpenes er a ungil el kirel me a ungil el kirel. Ng mlo er a ungil el live terpenes er a 5% me a ungil el 7-terpene profile (limonene, myrcene, caryophyllene, pinene, linalool, humulene, me a terpinolene) el kmo a terpene bioactivity a mlo er a ungil el kirel el mo er a ungil el kirel.
3. THCa el kmo a Separate Ingredient: A RSO el kmal mlo ungil a mlo er a ungil el kirel el mo er a ungil el kirel, a mlo er a ungil el kirel el mo er a THC. Ng ungil el sublingual formula a mlo er a THCa er a 1,500 mg el kmo a ungil el ingredient, a mlo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel.
4. Reduced Delta-9 THC Dominance: A RSO el kmal mlo ungil a mlo er a ungil el delta-9 THC (60-90%). Ng ungil el formula a mlo er a ungil el cannabinoids el mo er a ungil el kirel, me a delta-9 THC a mlo er a 90 mg me a delta-8 THC a mlo er a 6,000 mg, me a CBD (4,500 mg), CBG (3,000 mg), CBN (750 mg), me a CBC (750 mg).
5. Product Format Innovation: A Simpson a mlo er a ungil el format—ungil el oil. Ng mlo er a ungil el sublingual oil me a 1-gram vape cartridge, el kmo ngara e le me a ungil el mo er a ungil el kirel me a ungil el kirel.

Solvent Safety me a Extraction Evolution

Ng ngara e le me a ungil el kirel el mo er a RSO el kmal mlo ungil a mlo er a naphtha me a isopropyl alcohol, ng ngara e ng mla er a ungil el kirel. A naphtha, el kmo ng mla er a ungil el kirel, a mlo er a ungil el kirel el mo er a ungil el kirel. A ungil el kirel el mo er a ungil el kirel a mlo er a food-grade ethanol me a supercritical CO₂, el kmo a mlo er a ungil el kirel el mo er a ungil el kirel me a mlo er a ungil el kirel el mo er a ungil el kirel.

Er a OilWell, ng ungil el RSO a kmal mlo diak el kmo a extraction product er a ungil el kirel. Ng kmo a ungil el blend er a ungil el cannabinoid distillates me a isolates el mo er a ungil el ratio er a ungil el kirel. Ng kmal mlo diak el mo er a ungil el kirel. Ng mlo er a organic MCT oil (medium-chain triglycerides) el kmo a carrier base, el kmo a mlo er a ungil el kirel el mo er a ungil el kirel me a ungil el kirel.

A Decarboxylation Choice: Patient-Controlled Potency

A RSO el kmal mlo ungil a mlo er a ungil el kirel, el kmo a THCa a mlo er a ungil el kirel el mo er a THC, a mlo er a ungil el kirel el mo er a ungil el kirel. Ng ungil el sublingual formula a mlo er a 1,500 mg er a THCa er a ungil el form, el kmo ng ngara e le me a ungil el kirel. Ng ngara e le me a ungil el kirel el mo er a chad er a beluu:

1. Raw, No Heat: Ng ngara e le me a 1,500 mg a mlo er a THCa—el kmal mlo diak el mo er a ungil el kirel. Ng ngara e le me a ungil el kirel el mo er a ungil el kirel, me a ungil el kirel.
2. Fully Activated, Home Decarboxylation: A mlo er a ungil el kirel el mo er a ungil el kirel er a 260°F (125°C) er a ungil el 45-60 el minuets a mlo er a ungil el kirel el mo er a 1,500 mg er a THCa el mo er a 1,315 mg er a delta-9 THC. Er a ungil el 90 mg er a delta-9 THC, ng ngara e le me a 1,405 mg er a total delta-9 THC, el kmo a mlo er a ungil el kirel el mo er a RSO el kmal mlo ungil.
3. Vape, Auto-Decarboxylation: A RSO Vape Cartridge a mlo er a ungil el kirel er a 400-450°F, a mlo er a ungil el kirel el mo er a THCa el mo er a delta-9 THC me a ungil el kirel. Ng ngara e le me a ungil el kirel el mo er a ungil el kirel.

Ng ngara e le me a ungil el kirel el mo er a chad er a beluu, el kmo a ungil el kirel er a Simpson el kmo a chad er a beluu a mlo er a ungil el kirel el mo er a ungil el kirel; ng mlo er a ungil el product el mo er a ungil el kirel el mo er a chad er a beluu.

Terpene Loss er a RSO el kmal mlo ungil

A terpenes a mlo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel. A ungil el kirel el cannabis terpenes a mlo er a ungil el kirel el mo er a ungil el kirel er a ungil el 21°C me a 157°C. A ungil el kirel el mo er a RSO el kmal mlo ungil a mlo er a ungil el kirel er a ungil el 2 el ungil el kirel: er a mlo er a ungil el kirel er a ungil el kirel me a mlo er a ungil el kirel el mo er a ungil el kirel er a ungil el kirel el mo er a ungil el kirel.

Er a OilWell, ng mlo er a ungil el live terpenes er a 5% me a ungil el 7-terpene profile. Ng ungil el terpene a mlo er a ungil el kirel:

• Limonene: Citrus-bright, a mlo er a ungil el kirel el mo er a ungil el kirel me a ungil el kirel.
• Myrcene: Earthy me a musky, a mlo er a ungil el kirel el mo er a ungil el kirel.
• Caryophyllene (β-caryophyllene): Peppery me a spicy, a mlo er a ungil el kirel el mo er a CB2 receptors.
• Pinene: Piney me a fresh, a mlo er a ungil el kirel el mo er a ungil el kirel me a ungil el kirel.
• Linalool: Floral me a lavender-like, a mlo er a ungil el kirel el mo er a ungil el kirel.
• Humulene: Earthy me a woody, a mlo er a ungil el kirel el mo er a ungil el kirel.
• Terpinolene: Piney, fruity, me a sparkling, a mlo er a ungil el kirel el mo er a ungil el kirel.

Evidence Standards Then me a Ngara e ng ungil er a cheldecheduch

A Rick Simpson a mlo er a ungil el kirel er a ungil el era el kmal mlo diak el mo er a lab testing. Ng ungil el kirel a mlo er a ungil el kirel, ng ungil el production a mlo er a ungil el kirel, me ng ungil el kirel a mlo er a ungil el kirel. Er a cheldecheduch, ng mlo er a ungil el literature, clinical trials, me a institutional summaries. Er a OilWell, ng mlo er a ungil el evidence hierarchy:

1. Human clinical evidence
2. Systematic reviews me a meta-analyses
3. Institutional summaries (e.g., NIH, NCI)
4. Preclinical me a mechanistic literature

Ng ngara e le me a ungil el kirel el mo er a ungil el kirel el mo er a ungil el science, ng kmal mlo diak el mo er a ungil el kirel me a ungil el kirel.

A ungil el kirel er a Simpson vs. Modern Dosing Considerations

A ungil el kirel er a Simpson el 60-gram/90-day a mlo er a ungil el kirel el mo er a ungil el strain, THC-dominant extract. A ungil el kirel el mo er a ungil el kirel, multi-cannabinoid formulas el kmo ng ungil a kmal mlo diak el mo er a ungil el kirel. Ng ngara e le me a ungil:

• Cannabinoid Concentration: Ng ungil el sublingual formula a mlo er a 553 mg er a total cannabinoids per mL er a 7 el defined compounds. A RSO el kmal mlo ungil a mlo er a ungil el kirel me a ungil el kirel.
• Cannabinoid Ratios: A ungil el oil er a Simpson a mlo er a 60-90% delta-9 THC. Ng ungil el formula a mlo er a 16,590 mg er a total cannabinoids er a CBD (4,500 mg), CBG (3,000 mg), delta-8 THC (6,000 mg), THCa (1,500 mg), delta-9 THC (90 mg), CBN (750 mg), me a CBC (750 mg).
• Terpene Presence: A ungil el oil er a Simpson a kmal mlo diak el mo er a terpenes. Ng ungil el formula a mlo er a live terpenes er a 5%, el kmo a mlo er a ungil el kirel el mo er a ungil el kirel, effect, me a tolerability.
• Delta-9 THC Exposure: A ungil el kirel er a Simpson a mlo er a 600-900 mg er a delta-9 THC el me er a cheldecheduch. Ng ungil el sublingual formula a mlo er a 90 mg er a delta-9 THC er a ungil el 30 mL bottle (3 mg per mL).

A ungil el kirel el mo er a OilWell products a mlo er a ungil el kirel el mo er a ungil el kirel er a ungil el kirel me a ungil el titration principles.

OilWell Cannabis: Ng ungil el kirel me a ungil el mission

Er a McAllen el mo er a Montrose: Colin Valencia’s Journey

A OilWell Cannabis a mla mo diak el kmo Colin Valencia er a Houston, Texas. A ungil el kirel er a Colin a mla er a McAllen, Texas, el kmo ng mla er a U.S.-Mexico border. A McAllen a mlo er a ungil el klalo el ta er a Reynosa, Tamaulipas, Mexico. Ng ungil el klalo el ta a mlo er a ungil el kirel, me a kmal mlo ungil el mo er a ungil el kirel.

A ungil el kirel er a Colin er a McAllen a mlo er a ungil el kirel el mo er a ungil el kirel er a klalo el ta. Ng mlo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel. Ng ungil el kirel a mlo er a ungil el kirel el mo er a ungil el kirel. Er a ungil el 16 el ta, a Colin a mlo er a ungil el kirel el mo er a ungil el kirel.

Ng ngara e ng mlo er a ungil el kirel, a Colin a mlo er a ungil el kirel el mo er a ungil el kirel. Ng mlo er a ungil el kirel el mo er a ungil el kirel er a ungil el kirel el kmal mlo diak el mo er a ungil el kirel. Ng mlo er a ungil el kirel el mo er a ungil el kirel er a ungil el kirel el mo er a ungil el kirel.

A Colin a mlo er a formally trained software engineer me a mlo er a custom development work er a Baylor College of Medicine, el kmo ng ngara e le me a ungil el medical institution er a Texas Medical Center. Ng ungil el kirel er a ungil el kirel el cannabis me a medical-grade technical precision a mlo er a ungil el kirel er a OilWell.

Bentley: A chimal el ng kmal mlo ungil el mo er a cheldecheduch

A ungil el kirel er a company a mla er a chimal el ngar er a Bentley. A Bentley a kmal mlo diak el kmo a pet—ng kmal mlo ungil el mo er a cheldecheduch. Ng mlo er a ungil el kirel el mo er a Colin er a ungil el kirel el mo er a ungil el kirel. Ng veterinarians a mlo er a ungil el kirel el mo er a ungil el kirel: euthanasia a mlo er a ungil el kirel. A Bentley a mlo er a ungil el kirel er a ungil el kirel, me a ungil el kirel a mlo er a ungil el kirel el mo er a ungil el kirel.

A mlo er a ungil el kirel el mo er a ungil el kirel a kmal mlo diak el mo er a option. A Colin a mlo er a ungil el kirel el mo er a ungil el kirel. Er a ungil el kirel, ng mlo er a ungil el kirel el mo er a ungil el kirel el mo er a CBD. A ungil el rescue worker a Jessica a mlo er a ungil el kirel el kmo, “Ng mlo er a ungil el kirel el mo er a ungil el kirel el kmal mlo diak el mo er a CBD?”

A Colin a mlo er a ungil el kirel el cannabis, ng mlo er a ungil el kirel. Ng kmal mlo diak el mo er a ungil el kirel. A Jessica a mlo er a ungil el kirel a mlo er a ungil el kirel el mo er a ungil el kirel. A Colin a mlo er a ungil el kirel el mo er a ungil el kirel el mo er a CBD golden paste. Ng kmal mlo diak el kmo a cure, ng kmal mlo ungil el kmo a ungil el kirel—a mlo er a ungil el kirel el mo er a ungil el kirel: a Bentley a mlo er a ungil el kirel. Ng mlo er a ungil el kirel el mo er a Colin me a mlo er a ungil el kirel el mo er a ungil el kirel.

A Bentley a mlo er a ungil el 10 el ta, a mlo er a ungil el kirel er a ungil el 20 el ta. Er a ungil el ta, a Colin a mlo er a ungil el kirel el cannabis formulas el mo er a ungil el kirel el mo er a ungil el kirel el mo er a Bentley:

• Neurodegeneration: A mlo er a ungil el kirel el mo er a ungil el kirel el CBG’s neuroprotective properties me a THCa’s PPARγ agonism el mo er a ungil el kirel el mo er a ungil el kirel.
• Dementia: A mlo er a ungil el kirel el mo er a CBC’s role er a neurogenesis.
• Glaucoma: A mlo er a ungil el kirel el mo er a THC’s CB1 agonism el mo er a ungil el kirel el mo er a ungil el kirel.
• Arthritis: A mlo er a ungil el kirel el mo er a multi-pathway anti-inflammatory approaches me a CBD, CBG, THCa, me a beta-caryophyllene.

A ungil el cannabinoid a kmal mlo diak el mo er a ungil el kirel. A ungil el kirel er a Bentley a mlo er a ungil el multi-cannabinoid synergy. A ungil el kirel el pharmaceutical a mlo er a ungil el kirel—ng ungil el kirel er a Bentley a mlo er a ungil el kirel el formula accuracy, ng kmal mlo diak el mo er a ungil el kirel.

A ungil el kirel er a Colin: Er a PTSD el mo er a Peace

A Colin a mlo er a ungil el kirel el mo er a pharmaceutical dependence. Ng mlo er a ungil el kirel el mo er a PTSD me a benzodiazepine addiction. Ng mlo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel me a cannabinoid knowledge a mlo er a ungil el kirel el mo er a ungil el kirel. A Peace Gummies formula, a mlo er a ungil el product er a OilWell, a mlo er a ungil el kirel er a midnight experiments er a ungil el kirel er a benzo withdrawal. Er a ungil el kirel el mo er a ungil el kirel, a OilWell a mlo er a ungil el Peace Gummies formula er a vape form, el kmo a Colin a mlo er a ungil el kirel el mo er a ungil el kirel me a severe PTSD.

A ungil el philosophy er a OilWell: Accessibility, Control, Transparency, me a Evidence

Er a OilWell, ng ungil el RSO philosophy a mlo er a 4 el ungil el principles:

1. Accessibility Over Gatekeeping: Ng kmal mlo diak el mo er a medical card. Ng ungil el chad er a ungil el 21 el ta el mo er a ungil el kirel. Ng mlo er a ungil el kirel er a U.S. me a international el mo er a chad er a beluu el mo er a ungil el kirel el local legality. A Simpson a mlo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel; ng mlo er a product me a distribution model el mo er a ungil el kirel.
2. Patient-Controlled Potency: A THCa a mlo er a ungil el form, el kmal mlo diak el mo er a ungil el kirel. A chad er a beluu a mlo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel. A Simpson a mlo er a ungil el kirel el mo er a chad er a beluu el mo er a ungil el kirel el mo er a ungil el kirel; ng mlo er a product el mo er a ungil el kirel el mo er a chad er a beluu el mo er a ungil el kirel el mo er a chemistry.
3. Open-Source Formulas: Ng mlo er a ungil el formulas el mo er a ungil el kirel—ungil el cannabinoid, ungil el milligram amount, ungil el percentage—el mo er a ungil el chad er a beluu el mo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel. A Simpson a mlo er a ungil el oil el mo er a ungil el kirel me a mlo er a ungil el kirel el mo er a ungil el kirel; ng mlo er a ungil el ethos er a modern cannabinoid marketplace el mo er a ungil el product el mo er a ungil el kirel me a mlo er a ungil el recipe.
4. Evidence-Informed, Not Evidence-Overstating: A GENERAL KNOWLEDGE section er a document a mlo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el science. A Simpson a mlo er a ungil el kirel el mo er a ungil el kirel; ng mlo er a ungil el access me a mlo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel.

Farm Bill Compliance me a THCa Legal Framework

A 2018 Farm Bill a mlo er a ungil el hemp me a hemp-derived products el mo er a ungil el 0.3% delta-9 THC er a dry weight er a U.S. federal level. Ng ngara e le me a ungil el framework a mlo er a ungil el design er a OilWell’s RSO product.

Ng ungil el RSO Sublingual Oil a mlo er a 90 milligrams er a delta-9 THC er a ungil el 30 mL bottle—3 milligrams per milliliter—el kmal mlo diak el mo er a 0.3% threshold. Ng ungil el cannabinoids er a formula a mlo er a hemp-derived. A product a mlo er a ungil el mo er a federal law me a ungil el states.

A THCa (tetrahydrocannabinolic acid) a mlo er a ungil el form, el kmal mlo diak el mo er a ungil el kirel, el mo er a delta-9 THC. Ng ngara e ng mla er a ungil el kirel, me ng ngara e le me a ungil el kirel. A THCa a mlo er a Farm Bill compliant er a point of sale el kmo ng kmal mlo diak el mo er a delta-9 THC.

A ungil el significance er a framework a mlo er a ungil el kirel. A chad er a beluu a mlo er a ungil el kirel el mo er a THCa el mo er a delta-9 THC er a ungil el kirel el mo er a ungil el kirel er a 260°F (125°C) er a ungil el 45-60 el minuets. Ng ngara e le me a mlo er a ungil el kirel el mo er a 1,500 milligrams er a THCa el mo er a 1,315 milligrams er a delta-9 THC. Er a ungil el 90 milligrams er a delta-9 THC, ng ngara e le me a mlo er a 1,405 milligrams er a total delta-9 THC—el kmo a mlo er a ungil el kirel el mo er a RSO el kmal mlo ungil, el mo er a ungil el kirel el mo er a chad er a beluu er a ungil el kirel.

Ng ngara e le me a ungil el product a mlo er a ungil el function el kmo a non-psychoactive anti-inflammatory (used raw) me a full-potency psychoactive cannabinoid product (after home decarboxylation). A chad er a beluu a mlo er a ungil el kirel, me a product a mlo er a ungil el mo er a ungil el beluu el mo er a ungil el cannabinoids a mlo er a ungil el kirel.

Open-Source Formulas: Ng ngara e ng mlo er a ungil el kirel

Ng mlo er a ungil el complete RSO formulas—ungil el cannabinoid, ungil el milligram amount, ungil el percentage—er a public documents, el kmo ng ngara er a document. A RSO Sublingual Oil me a RSO Vape Cartridge formulas a mlo er a ungil el kirel er a ungil el kirel er a guide.

A rationale a mlo er a ungil el kirel: ng ngara e ng mlo er a chad er a beluu el mo er a ungil el kirel el mo er a ungil el product—$129.99 er a sublingual oil, $49.99 er a vape cartridge—ng mlo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel, a mlo er a ungil el kirel el mo er a ungil el cannabinoid distillates me a isolates, me a mlo er a ungil el kirel.

Ng ngara e le me a ungil el ethos er a Rick Simpson. A Simpson a mlo er a ungil el oil el mo er a ungil el kirel me a mlo er a ungil el kirel el mo er a ungil el kirel. Ng kmal mlo diak el mo er a ungil el method. Ng mlo er a ungil el ethos er a modern cannabinoid marketplace: ng mlo er a ungil el product el mo er a ungil el kirel, lab-tested, standardized product el mo er a chad er a beluu el mo er a ungil el kirel, me ng mlo er a ungil el complete recipe el mo er a chad er a beluu el mo er a ungil el kirel.

El kmo a Colin a mlo er a ungil el kirel er a ABC13 er a 2019: “Ng kmal mlo diak el mo er a ungil el kirel el mo er a chad er a beluu. Ng kmal mlo diak el mo er a ungil el kirel el mo er a chad er a beluu el mo er a ungil el kirel. Ng mlo er a ungil el research el kmal mlo ungil el mo er a chad er a beluu el mo er a ungil el kirel me a mlo er a ungil el kirel el mo er a ungil el version el mo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel.”

A open-source philosophy a kmal mlo diak el mo er a RSO—ng mlo er a Bentley. Er a About Us page, a Colin a mlo er a ungil el actual CBD golden paste recipe el mo er a ungil el kirel el mo er a Bentley’s life, el kmo a ungil el chad er a beluu el mo er a ungil el kirel el mo er a ungil el kirel a mlo er a ungil el kirel.

Solvent-Free Production: Safety me a Transparency

Ng ungil el RSO a kmal mlo diak el kmo a extraction product er a ungil el kirel. Ng kmo a ungil el blend er a ungil el cannabinoid distillates me a isolates el mo er a ungil el ratio er a ungil el kirel. Ng kmal mlo diak el mo er a solvents er a finished product—ng kmal mlo diak el mo er a naphtha, ng kmal mlo diak el mo er a isopropyl alcohol, ng kmal mlo diak el mo er a butane.

Ng mlo er a organic MCT oil (medium-chain triglycerides) el kmo a carrier base. A MCT oil a mlo er a ungil el lipid carrier el mo er a ungil el kirel el mo er a ungil el kirel me a ungil el kirel el mo er a ungil el kirel.

A third-party lab testing a mlo er a ungil el cannabinoid potency, terpene profile, me a safety panels el mo er a pesticides, heavy metals, residual solvents, me a microbial contaminants. A Certificates of Analysis (COAs) a mlo er a ungil el kirel er a request me a mlo er a ungil el kirel er a website.

Ng ungil el Product Portfolio: Er a chelecha el RSO

Er a chelecha el RSO, a OilWell Cannabis a mlo er a ungil el cannabinoid products, el kmo ngara e le me a ungil el kirel er a Colin el mo er a ungil el kirel er a Bentley’s ten-year journey me a ungil el kirel el mo er a PTSD me a benzo withdrawal.

• Asshole Peach: Ng ungil el popular product, a Asshole Peach a mlo er a ungil el formula el mo er a ungil el kirel el mo er a ungil el kirel me a ungil el kirel. Ng kmal mlo ungil el mo er a veterans el mo er a ungil el kirel el mo er a ungil el kirel me a PTSD symptoms el mo er a ungil el kirel.
• Peace Gummies: A mlo er a ungil el kirel er a Colin’s own experience me a PTSD me a benzodiazepine addiction, a Peace Gummies a mlo er a ungil el kirel el mo er a ungil el kirel el mo er a Xanax cold turkey. A formula a mlo er a ungil el kirel er a vape form el mo er a ungil el kirel—Colin a mlo er a ungil el kirel el mo er a ungil el kirel me a severe PTSD.
• Custom Creations: Ng mlo er a ungil el custom-made products el mo er a ungil el kirel, el mo er a ungil el cannabinoid ratios, delivery formats, me a formulations el mo er a ungil el kirel. Ng ngara e le me a ungil el products el mo er a vegans, diabetics, me a chad er a beluu el mo er a ungil el kirel.

Ng ungil el Product Formats: Sublingual Oil me a Vape Cartridge

Ng mlo er a ungil el RSO formula er a 2 el delivery formats, el kmo ngara e le me a ungil el mo er a ungil el kirel me a ungil el kirel.

RSO Sublingual Oil – $129.99

• Format: 30 mL bottle (1 fl oz)
• Total Cannabinoids: 16,590 mg (553 mg per mL)
• Cannabinoid Breakdown:
  • CBD: 4,500 mg
  • CBG: 3,000 mg
  • Delta-8 THC: 6,000 mg
  • THCa: 1,500 mg
  • Delta-9 THC: 90 mg
  • CBN: 750 mg
  • CBC: 750 mg
• Terpenes: Live terpenes er a 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Carrier: Organic MCT oil
• Dosing: Graduated dropper el mo er a ungil el kirel er a 0.1 mL increments
• Onset: 15-45 el minuets (sublingual absorption er a oral mucosa)
• Peak Effects: 1-2 el ta
• Duration: 4-6 el ta
• Bioavailability: 13-19% (sublingual route partially bypasses first-pass liver metabolism)
• Approximate Doses per Bottle: 40-60, el kmo ng ngara e ng mlo er a serving size

RSO Vape Cartridge – $49.99

• Format: 1-gram cartridge
• Total Cannabinoids: 900 mg+
• Cannabinoid Breakdown (by percentage):
  • CBD: 30%
  • CBG: 20%
  • Delta-8 THC: 15%
  • THCa: 10%
  • CBN: 10%
  • CBC: 10%
• Terpenes: Live terpenes er a 5%+
• Compatibility: 510-thread universal battery
• Onset: 1-2 el minuets (fastest cannabinoid delivery method)
• Peak Effects: 10-15 el minuets
• Duration: 2-4 el ta
• Bioavailability: 10-35% (variable, dependent er a inhalation technique)
• THCa Decarboxylation: Automatic er a vaping temperature (400-450°F)

Ng ngara e ng mlo er a ungil el format

Use Case	Recommended Format	Rationale
Fast relief (acute pain, nausea, panic)	Vape	1-2 el minuets onset
Sustained relief (chronic pain, sleep)	Sublingual	4-6 el ta duration
Maximum bioavailability	Sublingual	13-19% absorption
Portability me a discretion	Vape	Compact, ng kmal mlo diak el mo er a measuring required
Precise dosing control	Sublingual	Graduated dropper er a 0.1 mL increments
Daytime non-psychoactive use	Sublingual (raw, no heat)	THCa stays inactive, zero impairment
Nighttime psychoactive use	Sublingual (decarbed) me a Vape	Activated THCa + delta-8 THC

Competitive Comparison: OilWell RSO vs. Alternatives

OilWell RSO vs. Texas TCUP Dispensary RSO

Dimension	TCUP Dispensary RSO	OilWell RSO
Cannabinoid Profile	THC-only (approx. 420 mg THC per 0.5 g syringe)	7 cannabinoids: CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC
CBG Content	0 mg	3,000 mg
CBN Content	0 mg	750 mg
CBC Content	0 mg	750 mg
Patient-Controlled Potency	No—always fully psychoactive	Yes—THCa non-psychoactive until heated by customer
Access Requirements	TCUP medical card me a qualifying condition	Age 21+ only, ng kmal mlo diak el mo er a medical card required
Delivery	Must travel er a physical dispensary location	Same-day delivery er a Houston, nationwide me a international shipping
Farm Bill Compliant	No—state medical cannabis program	Yes—less than 0.3% delta-9 THC

OilWell RSO vs. Hemp CBD RSO (e.g., Lazarus Naturals)

Dimension	Lazarus Naturals RSO (10 mL, 1,000 mg)	OilWell RSO (30 mL, 16,590 mg)
Total Cannabinoids	1,000 mg	16,590 mg
CBD Content	~950 mg	4,500 mg
CBG Content	15.5 mg	3,000 mg
CBN Content	0.7 mg	750 mg
Delta-8 THC	0 mg	6,000 mg
THCa (convertible to delta-9 THC)	Minimal	1,500 mg (converts to ~1,315 mg delta-9 THC)
Psychoactive Option	No meaningful psychoactive effect	Yes—via THCa decarboxylation me a delta-8 THC
Approximate Price	$40-$50	$129.99

Condition-Specific Usage Context er a Palauans

Important Disclaimer: A ungil el usage contexts a mlo er a ungil el kirel er a cannabinoid research cited er a GENERAL KNOWLEDGE section er a document me a OilWell’s formulation rationale. Ng ngara e ng mla er a medical prescriptions, ng kmal mlo diak el mo er a FDA-approved treatment protocols, me ng kmal mlo diak el mo er a substitute er a professional medical care. A ungil el products a kmal mlo diak el mo er a evaluation er a Food and Drug Administration me a kmal mlo diak el mo er a ungil el kirel el mo er a ungil el kirel, treat, cure, me a prevent any disease. Ng kmal mlo diak el mo er a ungil el healthcare provider before using cannabinoid products, el kmo ng ngara e ng mlo er a medical condition, a mlo er a ungil el medications, a mlo er a pregnant me a nursing, me a mlo er a ungil el health concerns. Ng kmal mlo diak el mo er a vehicles me a machinery er a ungil el kirel er a psychoactive cannabinoids.

Chemotherapy-Related Nausea me a Appetite Support

• Pre-Chemo: 0.5 el ngar er a 1.0 mL sublingual approximately 1 el ta before treatment.
• Acute Breakthrough Nausea: 2-3 vape puffs el mo er a ungil el kirel (1-2 el minuets onset).
• Post-Chemo: 0.5 mL sublingual every 6 el ta el mo er a ungil el kirel.
• Sleep Support During Treatment: 1.0 el ngar er a 2.0 mL sublingual before bed (delivers 25-50 mg CBN).
• Evidence Context: Delta-8 THC antiemetic evidence [9], delta-9 THC nausea me a vomiting evidence [1][13], CBD anxiolytic buffering [3].

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy)

• Daytime: 0.3 el ngar er a 0.5 mL raw sublingual—provides anti-inflammatory cannabinoid exposure el mo er a ungil el kirel.
• Nighttime: 0.5 el ngar er a 1.0 mL decarboxylated sublingual—combines pain relief me a CBN sleep support.
• Breakthrough Pain: Vape el mo er a ungil el kirel el mo er a ungil el kirel.
• Evidence Context: CBD pain evidence [4], delta-9 THC pain evidence [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12].

Sleep Support

• Before Bed: 1.0 el ngar er a 2.0 mL sublingual.
  • Er a 2.0 mL, ng ngara e le me a delivers 50 mg CBN—the dosage level investigated er a recent sleep literature.
  • Er a 1.0 mL, ng ngara e le me a delivers 25 mg CBN—above the 20 mg threshold associated me a reduced sleep disturbance er a published research.
• Evidence Context: CBN sleep evidence [16][17], cannabis me a sleep review literature.

Anxiety me a Stress

• Daytime Functional Relief: 0.3 mL raw sublingual—CBD me a CBG address anxiety-related pathways el mo er a ungil el kirel.
• Nighttime: 1.0 mL sublingual—full cannabinoid profile including CBN el mo er a sleep architecture.
• Evidence Context: CBD anxiety evidence [3], CBG pharmacology [7][8], limonene entourage-effect evidence [20].

General Titration Principle: Start low, go slow. Begin me a 0.25 el ngar er a 0.5 mL sublingual me a mlo er a ungil el kirel er a 2-3 el ta before increasing. A individual responses a mlo er a ungil el kirel er a body weight, metabolism, tolerance, concurrent medications, me a other factors.

Delivery me a Global Accessibility: Bringing RSO er a Palau

A OilWell a mlo er a ungil el same-day RSO delivery system er a Houston. Er a chelecha el Houston, ng mlo er a ungil el kirel er a nationwide me a international.

Houston Same-Day Delivery

Zone	Coverage	Delivery Fee	Typical Turnaround
Texas Medical Center	All 60+ TMC institutions (MD Anderson, Memorial Hermann, Methodist, Texas Children’s, St. Luke’s, me a more)	FREE	2-4 el ta
Inner Loop (610)	Downtown, Midtown, Montrose, Heights, Rice Village, Museum District, River Oaks, Upper Kirby, Galleria	$5	2-4 el ta
Within Beltway 8	Bellaire, Memorial, Spring Branch, South Houston, Pasadena (partial), Hobby Airport area	$10	3-5 el ta
Greater Houston Suburbs	Katy, Sugar Land, Pearland, Clear Lake, Woodlands, Cypress, Tomball, Humble, Kingwood	$15	4-6 el ta
Extended Region (60 miles)	Galveston, Baytown, Rosenberg, Conroe, La Porte, Seabrook	$20-$25	Same-day if ordered before 2 PM

Free delivery er a Texas Medical Center—the world’s largest medical complex me a over 10 million patient visits annually—reflects ng ungil el commitment el mo er a accessibility el mo er a chad er a beluu el mo er a ungil el kirel.

Nationwide Shipping

• Coverage: All 50 states el mo er a Farm Bill-compliant products a mlo er a ungil el kirel.
• Carriers: USPS Priority Mail (2-3 business days), FedEx me a UPS Ground (3-5 business days).
• Packaging: Discreet, me a kmal mlo diak el mo er a cannabis branding visible.
• Tracking: Provided er a ungil el orders.
• Temperature Control: Temperature-stable packaging er a summer shipments.
• Signature Option: Signature-required option available.

International Shipping er a Palau

A OilWell a mlo er a ungil el kirel er a international me a mlo er a delivery er a ungil el beluu er a ungil el continents. A THCa legal framework a mlo er a ungil el kirel: el kmo ng ungil el product a mlo er a ungil el 0.3% delta-9 THC er a point of sale, ng mlo er a ungil el definition er a hemp-derived product er a 2018 Farm Bill me a mlo er a ungil el kirel er a jurisdictions me a compatible hemp laws, including Palau.

• Documentation: All international packages a mlo er a ungil el documentation, Certificates of Analysis (COAs), me a receipts er a customs purposes.
• Shipping Costs: Minimum flat-fee shipping applies; excessive international shipping costs a mlo er a billing er a chad er a beluu.
• Legal Responsibility: A chad er a beluu a mlo er a ungil el kirel el mo er a ungil el legality er a Palau me a mlo er a ungil el customs me a legal risk.
• Contact: (832) 416-2816 me a [email protected] er a international inquiries.

Important Note er a Palauan Customers:
Before ordering, ng mlo er a ungil el kirel el mo er a current legal status er a hemp-derived cannabinoid products er a Palau. El kmo a OilWell’s products a mlo er a compliance me a U.S. federal law (less than 0.3% delta-9 THC), a local regulations er a Palau a mlo er a ungil el kirel. Ng ngara e ng mlo er a ungil el kirel el mo er a compliance me a Palauan laws regarding the importation, possession, me a use er a cannabinoid products.

Ng ngara e le me a OilWell’s Formulas a mlo er a ungil el kirel er a Evidence

Ng ungil el cannabinoid er a OilWell’s formula—CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, me a CBC—a mlo er a ungil el evidence profile er a GENERAL KNOWLEDGE section er a document. Ng ungil el terpene—limonene, myrcene, caryophyllene, pinene, linalool, humulene, me a terpinolene—a mlo er a ungil el kirel me a preclinical me a review-level evidence.

Ng ungil el formulas a kmal mlo diak el kmo a standalone product listings. A mlo er a ungil el kirel er a per-compound evidence summaries el mo er a ungil el kirel el mo er a ngara e ng mlo er a ungil el kirel er a human clinical data, ng ngara e ng mlo er a ungil el kirel er a review me a preclinical literature, me ng ngara e ng mlo er a ungil el kirel. El kmo ng ngara e ng mlo er a ungil el research claims about individual cannabinoids me a terpenes, a document a mlo er a ungil el source evaluation context—the same peer-reviewed citations, the same evidence-tier assessments, me a same cautious interpretation framework.

A GENERAL KNOWLEDGE section’s evidence hierarchy, overstatement warnings, me a safety notes a mlo er a ungil el kirel er a OilWell’s own products. Ng ngara e ng mlo er a intentional. Ng ungil el position—el kmo a mlo er a ungil el kirel er a Colin Valencia er a 2019—a mlo er a ungil el kirel el mo er a ungil el version er a information el mo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel.

Media Recognition: OilWell’s Credibility er a Cannabis Industry

Er a 2019 me a 2023, a ABC13 Houston (KTRK)—a ABC affiliate serving America’s fourth-largest city—a mlo er a ungil el kirel er a Colin Valencia me a OilWell Cannabis er a 7 el ungil el news segments. A ungil el features a mlo er a ungil el kirel er a business, law, medicine, community health, me a politics, a mlo er a ungil el kirel er a Colin el kmo a go-to cannabis authority er a Houston. Ng ngara e le me a summary er a coverage:

1. September 15, 2019: “Texas CBD businesses booming as industry continues to evolve” – A ungil el quote er a Colin: “Ng kmal mlo diak el mo er a ungil el kirel el mo er a chad er a beluu. Ng kmal mlo diak el mo er a ungil el kirel el mo er a chad er a beluu el mo er a ungil el kirel. Ng mlo er a ungil el research el kmal mlo ungil el mo er a chad er a beluu el mo er a ungil el kirel me a mlo er a ungil el kirel el mo er a ungil el version el mo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel.”
2. March 22, 2021: “Entrepreneur creates direct-to-consumer business ahead of marijuana decriminalization efforts” – A Colin a mlo er a ungil el kirel el mo er a therapeutic potential er a cannabis el mo er a ungil el kirel.
3. May 24, 2021: “What is Delta 8 THC and why is it considered ‘legal weed’ in Texas?” – A ungil el honesty er a Colin: “Ng kmal mlo diak el mo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel. Ng ngara e ng mlo er a ungil el kirel el mo er a ungil el kirel.”
4. August 20, 2021: “Houston CBD shop giving away free products to those who get COVID vaccine” – A OilWell a mlo er a ungil el kirel el mo er a $35,000 er a product el mo er a ungil el kirel el mo er a vaccination, coordinated me a city er a Houston.
5. October 19, 2021: “Texas’ ban over once legal hemp product, Delta 8, raises questions over legality” – A Colin a mlo er a ungil el kirel el mo er a ungil el Delta-8 products before enforcement began me a mlo er a ungil el kirel er a other operators.
6. October 7, 2022: “Biden marijuana pardon — experts weigh in on why Texas won’t see impact” – A Colin a mlo er a ungil el kirel el mo er a personal marijuana conviction history.
7. April 21, 2023: “‘I want it to be legalized’: Marijuana industry getting creative as Texas laws continue to change” – A Colin a mlo er a ungil el kirel el mo er a “Renaissance” er a cannabis industry.

A media record a mlo er a ungil el kirel el mo er a OilWell’s credibility, community commitment, me a leadership er a cannabis space. Ng ngara e le me a ungil el kirel a mlo er a ungil el kirel—ng mlo er a ungil el kirel er a expertise, integrity, me a genuine community impact.

General Knowledge: A Science Behind OilWell’s RSO

Research Method me a Evidence Weighting

Er a OilWell, ng mlo er a ungil el evidence er a order: human clinical evidence, systematic reviews me a meta-analyses, NIH me a other institutional summaries, then mechanistic me a preclinical literature er a ungil el human data a mlo er a ungil el kirel. Ng ngara e ng mlo er a important el kmo a evidence base a mlo er a ungil el kirel. A CBD me a delta-9 THC a mlo er a ungil el human literature; a delta-8 THC, THCa, CBG, CBN, CBC, me a ungil el terpenes a mlo er a ungil el reviews, animal work, me a early translational research.

Institutional Baseline er a NIH me a Related Sources

• Strongest Established Evidence: A National Center for Complementary me a Integrative Health (NCCIH) a mlo er a ungil el kirel el kmo a ungil el cannabinoid evidence a mlo er a ungil el kirel er a ungil el rare epilepsies, chemotherapy-related nausea me a vomiting, me a appetite me a weight-loss indications associated me a HIV/AIDS.
• Safety Concerns: A NCCIH a mlo er a ungil el kirel el mo er a impairment, motor vehicle crash risk, cannabis use disorder, pregnancy-related concerns, accidental pediatric exposure, contamination, labeling inaccuracy, me a THC-vape lung-injury concerns.
• FDA Position: A FDA a kmal mlo diak el mo er a ungil el cannabis plant itself er a medical use, el kmo a purified CBD (Epidiolex) me a synthetic THC-like drugs (dronabinol, nabilone) a mlo er a ungil el approvals.

Cannabinoids: Evidence Profiles

CBD

• Strongest Human Evidence: A purified CBD a mlo er a ungil el credible evidence er a seizure disorders, me a FDA approval er a ungil el forms er a epilepsy.
• Anxiety Research: A 2024 systematic review me a meta-analysis covering 316 participants a mlo er a ungil el kirel el anxiolytic signal, ng ngara e ng mlo er a clinical sample a mlo er a ungil el kirel.
• Pain Research: A 2024 systematic review a mlo er a ungil el kirel el promising but heterogeneous pain literature, me a trial quality me a consistency a mlo er a ungil el kirel el confidence.
• Sleep Research: A 2023 insomnia review a mlo er a ungil el kirel el literature a mlo er a methodologically weak, me a kmal mlo diak el mo er a objective sleep assessments.
• Safety Concerns: A 2023 systematic review a mlo er a ungil el kirel el signal er a liver enzyme elevation me a possible drug-induced liver injury er a ungil el contexts.
• Bottom Line: A CBD a mlo er a ungil el evidence-developed nonintoxicating cannabinoid, ng ngara e ng mlo er a strong evidence a mlo er a ungil el specific indications rather than broad wellness claims.

CBG

• Evidence Profile: Mostly review-level me a preclinical; human evidence a mlo er a ungil el kirel.
• Pharmacology: A CBG a mlo er a ungil el kirel el mo er a cannabinoid receptors, alpha-2 adrenoceptors, me a 5-HT1A-related signaling.
• Potential Research Areas: Neurologic disorders, inflammatory bowel disease, me a antibacterial activity a mlo er a ungil el kirel er a reviews, ng ngara e ng mlo er a preclinical findings.
• Caution: A CBG a mlo er a ungil el kirel el mo er a commercial while the evidence base a mlo er a ungil el kirel.
• Bottom Line: A CBG a mlo er a ungil el minor cannabinoid me a ungil el clinical validation.

Delta-8 THC

• Evidence Profile: Pharmacologically relevant, psychoactive, me a less clinically characterized than delta-9 THC.
• Comparative Pharmacology: A delta-8 THC a mlo er a partial CB1 agonist me a cannabimimetic activity, ng ngara e ng mlo er a less potent than delta-9 THC.
• Public-Health Literature: A 2023 scoping review a mlo er a ungil el kirel el kmo a ungil el delta-8 evidence base a mlo er a dominated er a animal studies, product chemistry, me a public-health concerns rather than strong human trials.
• Manufacturing Context: A delta-8 THC a mlo er a ungil el kirel er a CBD, el kmo a mlo er a ungil el byproducts me a quality concerns.
• Bottom Line: A delta-8 THC a mlo er a ungil el psychoactive THC analogue me a incomplete human safety characterization.

THCa

• Evidence Profile: Important chemically, ng ngara e ng mlo er a low er a direct human therapeutic evidence.
• Ng ngara e le: A THCa a mlo er a ungil el precursor el mo er a THC. Ng mlo er a decarboxylates el mo er a THC er a ungil el kirel me a mlo er a ungil el kirel er a storage.
• Psychoactivity: A THCa itself a kmal mlo diak el mo er a psychoactive effects, ng ngara e ng mlo er a ungil el kirel el mo er a ungil el form.
• Research Status: In vitro me a rodent literature a mlo er a ungil el kirel el anti-inflammatory, immunomodulatory, neuroprotective, me a antineoplastic possibilities.
• Bottom Line: A THCa a mlo er a ungil el kirel el kmo a precursor molecule el mo er a ungil el kirel el kmo ng ngara e ng mlo er a route, temperature, processing, me a storage.

Delta-9 THC

• Evidence Profile: Strongest human evidence er a psychoactive cannabinoids, ng ngara e ng mlo er a ungil el adverse-effect burden.
• Best-Supported Indications: Chemotherapy-related nausea me a vomiting, appetite me a weight loss er a HIV/AIDS, me a ungil el pain-related outcomes.
• Pain Evidence: A 2022 systematic review a mlo er a ungil el kirel el kmo a high-THC products a mlo er a ungil el short-term pain benefit ng ngara e ng mlo er a ungil el dizziness, sedation, nausea, me a treatment discontinuation.
• Mental-Health Risk: A 2025 systematic review a mlo er a ungil el kirel el consistent unfavorable associations me a psychosis me a schizophrenia outcomes me a cannabis use disorder.
• Safety Concerns: Anxiety me a panic er a high doses, tachycardia, blood-pressure changes, dependency potential, withdrawal symptoms, pregnancy concerns, me a vape-related lung-injury concerns.
• Bottom Line: A delta-9 THC a mlo er a ungil el therapeutic relevance ng ngara e ng mlo er a significant intoxication, psychiatric, me a dose-related safety liabilities.

CBN

• Evidence Profile: Weak human evidence; marketing a mlo er a ungil el kirel el mo er a data.
• Marketed For: Sleep me a sedation.
• Sleep Evidence: A 2021 narrative review a mlo er a ungil el kirel el kmo ng kmal mlo diak el mo er a clinical trials using validated sleep questionnaires me a polysomnography el mo er a substantiate sleep-promoting claims.
• Bottom Line: A CBN a mlo er a ungil el examples el kmo a cultural reputation a mlo er a stronger than the current clinical evidence base.

CBC

• Evidence Profile: Emerging, intriguing, me a still overwhelmingly preclinical.
• Pharmacology: A CBC a mlo er a ungil el pharmacodynamics me a receptor behavior relative el mo er a better-known cannabinoids.
• Research Areas: Antinociceptive, antibacterial, me a anti-seizure areas a mlo er a ungil el kirel er a reviews, ng ngara e ng mlo er a preclinical findings.
• Safety Caveat: A CBC products a mlo er a ungil el kirel el mo er a commercial despite little evidence establishing clinical efficacy me a safety.
• Bottom Line: A CBC a mlo er a scientifically credible minor cannabinoid el mo er a ungil el research.

Terpenes: Evidence me a Interpretation

A terpene claims a mlo er a ungil el kirel el careful interpretation. A ungil el terpene literature a mlo er a ungil el kirel er a isolated compounds, essential oils, me a preclinical models rather than controlled human studies er a cannabis formulations.

Limonene

• Evidence Profile: Largely review me a preclinical.
• Potential Activity: Antioxidant, anti-inflammatory, cardioprotective, gastroprotective, me a immune-modulatory effects a mlo er a ungil el kirel er a reviews.
• Safety Note: A limonene oxidation products a mlo er a clinically relevant contact allergens.
• Bottom Line: A limonene a mlo er a biologically active ng ngara e ng mlo er a cannabis-specific therapeutic claims a mlo er a conservative.

Myrcene

• Evidence Profile: Mostly preclinical, me a very limited human evidence.
• Research Summary: Anxiolytic, antioxidant, anti-inflammatory, me a analgesic properties a mlo er a ungil el kirel er a reviews.
• Interpretation Caution: A myrcene a mlo er a ungil el kirel el kmo a sedating terpene, ng ngara e ng mlo er a ungil el claim a mlo er a stronger than the human evidence supports.
• Bottom Line: A myrcene a mlo er a plausible bioactive terpene, ng ngara e ng mlo er a compound-specific clinical claims a mlo er a ungil el kirel el carefully.

Caryophyllene (β-Caryophyllene)

• Evidence Profile: Mechanistically interesting due el mo er a direct CB2 receptor agonism.
• Ng ngara e ng mlo er a ungil el kirel: Unique among terpenes er a cannabinoid-system relevance.
• Research Themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, me a gastroprotective actions a mlo er a ungil el kirel er a reviews.
• Bottom Line: A beta-caryophyllene a mlo er a ungil el candidate el mo er a terpene me a cannabinoid-system significance, ng ngara e ng mlo er a clinical proof a mlo er a ungil el kirel.

Pinene

• Evidence Profile: Promising preclinical literature, weak human clinical confirmation.
• Brain-Health Framing: Antioxidant, anti-inflammatory, me a neuroprotective signals a mlo er a ungil el kirel er a reviews.
• Interpretation Caution: A claims about memory improvement me a attention sharpening a mlo er a hypotheses.
• Bottom Line: A pinene a mlo er a ungil el scientific attention, ng ngara e ng mlo er a strong cognition-related claims a mlo er a ungil el kirel el kmo a exploratory.

Linalool

• Evidence Profile: Similar el mo er a pinene—substantial preclinical interest, limited clinical confirmation.
• Research Summary: Stress, mood, me a brain-health pharmacology a mlo er a ungil el kirel er a reviews.
• Safety Note: Oxidized linalool hydroperoxides a mlo er a recognized allergens er a dermatitis literature.
• Bottom Line: A linalool a mlo er a scientifically credible el kmo a bioactive terpene, ng ngara e ng mlo er a current evidence supports cautious phrasing.

Humulene

• Evidence Profile: Translationally interesting, ng ngara e ng mlo er a early.
• Scoping-Review Findings: Broad preclinical evidence er a anti-inflammatory me a other biologic effects.
• Bottom Line: A humulene a mlo er a ungil el interesting terpene research targets, ng ngara e ng mlo er a far from clinically settled.

Terpinolene

• Evidence Profile: One er a ungil el clinically characterized terpenes.
• Systematic-Review Findings: A 2021 review a mlo er a ungil el kirel el kmo a terpinolene a mlo er a range er a reported biological effects, ng ngara e ng mlo er a evidence base a mlo er a dominated er a in silico, in vitro, me a animal studies.
• Bottom Line: A terpinolene a mlo er a biologically interesting ng ngara e ng mlo er a especially underdeveloped clinically.

Research Limits me a Interpretation

• Evidence Is Uneven: A CBD me a delta-9 THC a mlo er a ungil el human-facing statements; a ungil el a mlo er a ungil el kirel.
• Data Categories Are Not Interchangeable: Whole-cannabis extract data, purified-molecule data, semisynthetic cannabinoid data, me a terpene-only data a kmal mlo diak el kmo a equivalent.
• Minor Cannabinoids me a Terpenes Are Underexplored: Ng ngara e ng mlo er a commercially interesting, ng ngara e ng mlo er a claims often become inflated.
• Product Quality Matters: Labeling inaccuracies, contamination, synthesis byproducts, dose variability, me a route-dependent pharmacokinetics all affect real-world interpretation.
• THCa Chemistry Is Dynamic: Storage me a heating a mlo er a ungil el kirel el actual exposure profile.

Common Overstatements el mo er a Avoid

• Overstatement: A CBN a mlo er a clinically proven sleep cannabinoid.
  More Accurate: A ungil el sleep evidence er a CBN a mlo er a weak me a dated.
• Overstatement: A myrcene a mlo er a proven human sedative el mo er a couch-lock.
  More Accurate: A myrcene a mlo er a plausible preclinical bioactivity, ng ngara e ng mlo er a direct human proof a mlo er a ungil el kirel.
• Overstatement: A terpenes a mlo er a proven entourage effects er a chad er a beluu.
  More Accurate: A entourage hypotheses a mlo er a influential, ng ngara e ng mlo er a robust clinical proof a mlo er a ungil el kirel.
• Overstatement: A THCa a kmal mlo diak el mo er a psychoactive.
  More Accurate: A THCa itself a kmal mlo diak el mo er a THC, ng ngara e ng mlo er a heating me a processing a mlo er a ungil el kirel el mo er a THC.
• Overstatement: A delta-8 THC a mlo er a ungil el kirel el kmo ng mlo er a hemp-derived.
  More Accurate: A delta-8 THC a mlo er a psychoactive me a often entangled me a manufacturing me a testing concerns.

Practical Takeaways er a OilWell’s Formulas

• Most Evidence-Developed Actives: CBD me a delta-9 THC.
• Delta-8 THC: A psychoactive cannabinoid me a less robust safety me a efficacy characterization than delta-9 THC.
• THCa: Meaningfully changes me a processing me a mlo er a ungil el kirel el mo er a ungil el kirel er a raw, gently handled, me a heated formats.
• CBG, CBN, CBC: Scientifically credible ng ngara e ng mlo er a clinically immature compared el mo er a CBD me a THC.
• Terpenes: Likely relevant el mo er a aroma, flavor, me a ungil el biologic activity, ng ngara e ng mlo er a compound-specific human therapeutic claims a mlo er a ungil el kirel el carefully.

OilWell RSO Formulas: Ng ngara e ng mlo er a ungil

RSO Sublingual Oil

Cannabinoid	Amount (mg)
CBD	4,500
CBG	3,000
Delta-8 THC	6,000
THCa	1,500
Delta-9 THC	90
CBN	750
CBC	750
Total	16,590

• Live Terpenes: 5%
• Format: 30 mL bottle
• Active cannabinoids per mL: 553 mg

RSO Vape Cartridge

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%
• Format: 1-gram cartridge

Terpene Profile (Both Products)

• Limonene: Citrus-bright, a mlo er a ungil el kirel el mo er a ungil el kirel me a ungil el kirel.
• Myrcene: Earthy me a musky, a mlo er a ungil el kirel el mo er a ungil el kirel.
• Caryophyllene (β-caryophyllene): Peppery me a spicy, a mlo er a ungil el kirel el mo er a CB2 receptor interaction.
• Pinene: Piney me a fresh, a mlo er a ungil el kirel el mo er a ungil el kirel me a ungil el kirel.
• Linalool: Floral me a lavender-like, a mlo er a ungil el kirel el mo er a ungil el kirel.
• Humulene: Earthy me a woody, a mlo er a ungil el kirel el mo er a ungil el kirel.
• Terpinolene: Piney, fruity, me a sparkling, a mlo er a ungil el kirel el mo er a ungil el kirel.

Legal Compliance me a Safety: Ng ngara e ng mlo er a ungil el kirel er a Palauans

Age Requirements

A OilWell’s RSO products a mlo er a ungil el mo er a adults el ungil el 21 el ta el mo er a ungil el kirel.

THC Content Compliance

All OilWell products a mlo er a ungil el 0.3% delta-9 THC me a mlo er a compliance me a 2018 U.S. Farm Bill. Ng ngara e le me a mlo er a ungil el mo er a U.S. federal law me a ungil el states.

FDA Disclaimers

A ungil el products a kmal mlo diak el mo er a evaluation er a Food and Drug Administration. Ng kmal mlo diak el mo er a ungil el kirel el mo er a ungil el kirel, treat, cure, me a prevent any disease. Ng kmal mlo diak el mo er a ungil el healthcare provider before using cannabinoid products, el kmo ng ngara e ng mlo er a medical condition, a mlo er a ungil el medications, a mlo er a pregnant me a nursing, me a mlo er a ungil el health concerns. A individual results a mlo er a ungil el kirel.

Safety Warnings

• May cause drowsiness me a impairment. Ng kmal mlo diak el mo er a vehicles me a machinery er a ungil el kirel er a psychoactive cannabinoids.
• Consult a physician if pregnant me a nursing.
• Keep out of reach of children.
• Store er a cool, dry place away from direct sunlight.

Legal Responsibility

Ng ngara e ng mlo er a ungil el kirel el mo er a local laws regarding the purchase, possession, me a use er a cannabinoid products. A OilWell a kmal mlo diak el mo er a legal responsibility er a customer’s use me a decarboxylation decisions. Void where prohibited by law.

Drug Testing Considerations

• THCa (Raw): A THCa er a raw form a kmal mlo diak el mo er a psychoactive me a mlo er a ungil el kirel el mo er a standard drug tests designed el mo er a ungil el kirel el delta-9 THC.
• Delta-8 THC me a Activated THCa: Both delta-8 THC me a activated THCa (after decarboxylation) a mlo er a ungil el kirel el mo er a positive results er a standard drug tests.
• Workplace Policies: If you are subject el mo er a drug testing, consult your employer’s policies before using any cannabinoid products.

Ng ngara e le me a OilWell RSO a mlo er a ungil el choice er a Palau

1. Evidence-Informed Formulation

Ng ungil el RSO a mlo er a formulation based er a ungil el science, ng kmal mlo diak el mo er a ungil el kirel me a ungil el kirel. Ng ungil el cannabinoid me a terpene er a formula a mlo er a ungil el evidence profile, el kmo ng mlo er a ungil el kirel er a guide.

2. Patient-Controlled Potency

Me a THCa included er a ungil el form, el kmal mlo diak el mo er a psychoactive, ng mlo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel el mo er a full psychoactive potency. Ng ngara e le me a ungil el control a mlo er a ungil el unique er a RSO market.

3. Open-Source Transparency

Ng mlo er a ungil el complete formulas el mo er a ungil el chad er a beluu el mo er a ungil el kirel el mo er a ungil el product. Ng ungil el commitment el mo er a accessibility me a transparency a mlo er a ungil el rare er a cannabis industry.

4. Solvent-Free Production

Ng ungil el RSO a mlo er a formulated blend er a ungil el cannabinoid distillates me a isolates, a mlo er a ungil el kirel el residual solvent risks associated me a traditional RSO production.

5. Two Product Formats

Ng mlo er a ungil el sublingual oil me a 1-gram vape cartridge, el kmo ngara e le me a ungil el mo er a ungil el kirel me a ungil el kirel. El kmo ng ngara e ng mlo er a ungil el kirel el mo er a fast relief me a sustained support, ng mlo er a ungil el format el mo er a ungil el kirel.

6. Lab-Tested Quality

Ng ungil el batch er a OilWell RSO a mlo er a ungil el third-party lab testing er a potency, terpenes, pesticides, heavy metals, residual solvents, me a microbial contaminants. A Certificates of Analysis (COAs) a mlo er a ungil el kirel er a request.

7. Global Accessibility

Ng mlo er a ungil el kirel er a nationwide er a U.S. me a international er a Palau me a beyond. Ng THCa legal framework a mlo er a ungil el kirel el mo er a ungil el products el mo er a jurisdictions el mo er a hemp-derived products me a ungil el 0.3% delta-9 THC a mlo er a ungil el kirel.

8. Community Commitment

Er a ungil el kirel el mo er a $35,000 er a product el mo er a ungil el kirel el mo er a COVID-19 vaccination me a ungil el kirel el mo er a ungil el Delta-8 products before enforcement began, ng ungil el actions a mlo er a ungil el kirel el mo er a community health me a ethical leadership.

9. Houston-Made, Houston-Proud

All ng ungil el products a mlo er a ungil el kirel er a Houston, Texas, using ng ungil el recipes me a ideas. Ng mlo er a Houston grit, McAllen roots, me a builder’s mindset el mo er a ungil el kirel.

Ng ngara e le me a ungil el OilWell RSO er a Palau

Step 1: Verify Legality

Before ordering, ng mlo er a ungil el kirel el mo er a current legal status er a hemp-derived cannabinoid products er a Palau. El kmo a OilWell’s products a mlo er a compliance me a U.S. federal law (less than 0.3% delta-9 THC), a local regulations er a Palau a mlo er a ungil el kirel.

Step 2: Choose Your Product

Decide which format best suits your needs:

• RSO Sublingual Oil: Ideal el mo er a sustained relief, precise dosing, me a daytime non-psychoactive use.
• RSO Vape Cartridge: Perfect el mo er a fast relief, portability, me a discretion.

Step 3: Place Your Order

Visit ng website el mo er a ungil el kirel. Er a international shipping er a Palau, select the appropriate shipping option me a mlo er a ungil el address me a contact information.

Step 4: Shipping me a Delivery

• Documentation: All international packages a mlo er a ungil el documentation, Certificates of Analysis (COAs), me a receipts er a customs purposes.
• Shipping Costs: A minimum flat-fee shipping applies. Excessive international shipping costs a mlo er a billing er a chad er a beluu.
• Delivery Time: International shipping times a mlo er a ungil el kirel. Once your order is processed, you will receive a tracking number el mo er a ungil el kirel el mo er a progress er a package.

Step 5: Receive me a Store Your Product

• Customs: Ng mlo er a ungil el kirel el mo er a compliance me a Palauan customs regulations. A OilWell a kmal mlo diak el mo er a responsibility er a customs delays me a seizures.
• Storage: Store your product er a cool, dry place away from direct sunlight el mo er a ungil el kirel el potency me a quality.

Step 6: Consult me a Healthcare Provider

Before using OilWell RSO, consult me a qualified healthcare provider, el kmo ng ngara e ng mlo er a medical condition, a mlo er a ungil el medications, me a ungil el health concerns.

Frequently Asked Questions (FAQs) er a Palauan Customers

Is OilWell RSO legal er a Palau?

A OilWell’s RSO products a mlo er a ungil el 0.3% delta-9 THC me a mlo er a compliance me a U.S. federal law. Ng ngara e ng mlo er a local regulations er a Palau a mlo er a ungil el kirel. Ng ngara e ng mlo er a ungil el kirel el mo er a compliance me a Palauan laws before ordering.

Will OilWell RSO make me high?

• Raw (No Heat): If used er a raw form, a THCa a kmal mlo diak el mo er a psychoactive, ng ngara e ng mlo er a ungil el kirel el mo er a high.
• Decarboxylated (Heated): If you decarboxylate the oil el mo er a ungil el kirel er a 260°F (125°C) er a ungil el 45-60 el minuets, a THCa a mlo er a ungil el kirel el mo er a delta-9 THC, producing psychoactive effects.
• Vape Cartridge: A vape cartridge a mlo er a automatic decarboxylation er a THCa er a vaping temperature (400-450°F), delivering psychoactive effects me a ungil el inhalation.

How do I decarboxylate OilWell RSO?

1. Preheat your oven el mo er a 260°F (125°C).
2. Place the desired amount er a oil er a oven-safe glass container.
3. Heat the oil er a oven er a ungil el 45-60 el minuets.
4. Allow the oil el mo er a cool before use.

How should I dose OilWell RSO?

Start low me a go slow. Begin me a 0.25 el ngar er a 0.5 mL sublingual me a mlo er a ungil el kirel er a 2-3 el ta before increasing. A individual responses a mlo er a ungil el kirel er a body weight, metabolism, tolerance, me a other factors.

Er a condition-specific guidance, refer el mo er a “Condition-Specific Usage Context” section earlier er a guide.

Can I travel me a OilWell RSO?

Traveling me a cannabinoid products a mlo er a ungil el kirel, especially international. El kmo a product a mlo er a ungil el mo er a U.S. me a Palau, a airport security me a customs regulations a mlo er a ungil el kirel. Ng kmal mlo diak el mo er a recommended el mo er a travel me a cannabinoid products unless you are certain er a legal me a security requirements er a destination.

Will OilWell RSO show up er a drug test?

• THCa (Raw): A THCa er a raw form a mlo er a ungil el kirel el mo er a standard drug tests designed el mo er a ungil el kirel el delta-9 THC.
• Delta-8 THC me a Activated THCa: Both delta-8 THC me a activated THCa (after decarboxylation) a mlo er a ungil el kirel el mo er a positive results er a standard drug tests.
• Workplace Policies: If you are subject el mo er a drug testing, consult your employer’s policies before using any cannabinoid products.

How do I store OilWell RSO?

Store your product er a cool, dry place away from direct sunlight el mo er a ungil el kirel el potency me a quality. A sublingual oil a mlo er a ungil el kirel el room temperature, ng ngara e ng mlo er a refrigeration a mlo er a ungil el kirel el shelf life.

What is the shelf life er a OilWell RSO?

When stored properly, a OilWell RSO a mlo er a shelf life er a approximately 1-2 el ta. Always check the expiration date er a packaging.

Can I use OilWell RSO for pets?

A OilWell RSO a mlo er a formulation el mo er a human use. While CBD a mlo er a ungil el kirel er a pets, ng ungil el RSO a mlo er a ungil el cannabinoids me a terpenes a kmal mlo diak el mo er a evaluation er a safety me a efficacy er a animals. If you are interested er a cannabinoid products for pets, ng mlo er a recommended el mo er a ungil el product specifically designed for animals, el kmo ng ungil el CBD golden paste recipe, a mlo er a ungil el kirel er a About Us page.

How does OilWell RSO compare er a traditional RSO?

A OilWell RSO a mlo er a modern, evidence-informed formulation el mo er a ungil el kirel el limitations er a traditional RSO. Ng ngara e le me a comparison:

Dimension	Traditional RSO	OilWell RSO
Cannabinoid Profile	THC-dominant, uncontrolled	7 defined cannabinoids er a ungil el ratios
Terpene Content	Destroyed er a ungil el kirel el process	Live terpenes er a 5% me a defined profile
Standardization	None—ungil el batch er a ungil el kirel	Lab-tested me a ungil el mg/mL targets
Residual Solvents	Significant risk me a naphtha	Controlled me a tested
THCa Preservation	No—fully decarboxylated er a heat	Yes—THCa included el kmo a separate ingredient
Evidence Approach	Anecdotal, personal testimony	Research-backed, evidence-weighted

Is OilWell RSO safe?

A OilWell RSO a mlo er a production using solvent-free methods me a mlo er a third-party lab testing er a potency, terpenes, pesticides, heavy metals, residual solvents, me a microbial contaminants. Ng ngara e ng mlo er a cannabinoid products a kmal mlo diak el mo er a risk-free. A potential side effects a mlo er a ungil el kirel el drowsiness, dry mouth, dizziness, me a changes er a appetite. Ng kmal mlo diak el mo er a healthcare provider before use, el kmo ng ngara e ng mlo er a medical condition me a mlo er a ungil el medications.

Can I use OilWell RSO while pregnant me a nursing?

No. A use er a cannabinoid products during pregnancy me a while nursing a kmal mlo diak el mo er a recommended. Consult your healthcare provider for guidance.

How do I contact OilWell Cannabis?

Er a questions about ng ungil el products, ordering, me a international shipping er a Palau, ng mlo er a ungil el kirel:

• Phone: (832) 416-2816
• Email: [email protected]
• Website: https://oilwellcbd.com/
• Address: 810 Richmond Ave, Houston, TX 77006 (Montrose neighborhood)

What if my order is delayed me a lost?

If your order is delayed me a lost, contact us immediately at [email protected] me a (832) 416-2816. Ng mlo er a ungil el kirel el mo er a ungil el kirel el mo er a ungil el kirel. Er a international orders, customs delays a mlo er a ungil el kirel, me ng kmal mlo diak el mo er a responsibility er a customs seizures me a delays.

Final Thoughts: Empowering Palau me a Honest Cannabis Education

Er a OilWell Cannabis, ng mlo er a ungil el kirel el kmo a ungil el chad er a Palau a mlo er a ungil el kirel el mo er a honest, science-based education about cannabis me a ungil el potential benefits. A ungil el kirel er a Rick Simpson a mlo er a ungil el kirel el mo er a global movement, ng ngara e ng mlo er a modern RSO a mlo er a ungil el kirel el mo er a ungil el kirel el traditional methods. Ng ungil el formulations a mlo er a built er a foundation er a evidence, transparency, me a patient empowerment.

El kmo ng ngara e ng mlo er a ungil el kirel el mo er a chronic pain, sleep, anxiety, me a other health concerns, a OilWell RSO a mlo er a modern, lab-tested, me a accessible option. Me a patient-controlled potency, open-source transparency, me a global accessibility, ng mlo er a commitment el mo er a ungil el Palauans me a ungil el version er a RSO—one el mo er a ungil el kirel el tradition while embracing innovation.

Kulo ra mo er a OilWell Cannabis. Ng mlo er a ungil el kirel el mo er a ungil el journey.

ENGLISH

Rick Simpson Oil (RSO) in Palau: The Complete Guide by OilWell Cannabis

Understanding RSO: From Tradition to Modern Science

Rick Simpson Oil (RSO) has become one of the most discussed cannabis extracts in Palau and around the world. But what exactly is RSO, and how does it fit into Palau’s health and wellness landscape? At OilWell Cannabis, we believe in providing Palauans with honest, science-based education about RSO—its history, its evolution, and how modern formulations like ours can offer safer, more effective options for those seeking natural support.

Who Was Rick Simpson?

Rick Simpson was a Canadian power engineer born in 1949 in Nova Scotia. His journey into cannabis advocacy began with personal suffering. In 1997, while working at a hospital in Moncton, New Brunswick, Simpson fell from scaffolding, resulting in a serious head injury. The aftermath included persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine couldn’t adequately address. When he asked his doctor about cannabis for relief, the request was refused.

Simpson’s interest in cannabis deepened after learning about a 1974 study funded by the U.S. National Institute of Health. The study, conducted at the Medical College of Virginia, found that THC could slow or shrink tumors in mice. Though these findings were never replicated in controlled human trials, they became a cornerstone of Simpson’s later advocacy.

The turning point came in 2003 when Simpson noticed three bumps on his arm. His doctor diagnosed them as basal cell carcinoma, a form of skin cancer. Instead of pursuing conventional treatment, Simpson applied concentrated cannabis oil to the lesions, covered them with bandages, and waited. According to his account, the bumps disappeared within four days. While this outcome was never independently verified or documented in peer-reviewed literature, it became the origin story of Rick Simpson Oil and the foundation of his global advocacy.

The Birth of RSO and Its Global Spread

After his 2003 experience, Simpson began producing and distributing concentrated cannabis oil for free to cancer patients and others in his community. He charged nothing, believing that this medicine should be accessible to everyone. His work gained global attention through the 2005 documentary Run From The Cure, which framed his efforts as a grassroots challenge to pharmaceutical and governmental interests.

Simpson’s advocacy, however, put him at odds with Canadian law. The Royal Canadian Mounted Police (RCMP) raided his property in 2005 and again in 2009, seizing plants and equipment. Facing legal pressure, Simpson eventually left Canada for Europe, continuing his advocacy from abroad. In 2012, he published Phoenix Tears: The Rick Simpson Story, detailing his experiences and methods, and maintained phoenixtears.ca as a platform for his message.

The Traditional RSO Protocol: What It Involved

Simpson’s core treatment recommendation was a structured 90-day protocol designed to deliver 60 grams of concentrated cannabis oil. Here’s how it worked:

1. Initial Dosing (Week 1): Patients started with a dose the size of half a grain of rice—about 10 to 15 milligrams of oil—three times a day.
2. Escalation (Weeks 2-5): The dose doubled approximately every four days, building tolerance to THC’s psychoactive effects. By the end of this period, patients were consuming about 1 gram of oil per day.
3. Maintenance (Weeks 5-12): Patients maintained the 1-gram daily dose until the full 60 grams were consumed.
4. Administration: Simpson recommended oral ingestion (sublingual or swallowed) as the primary method, with topical application for skin cancers and inhalation for symptom relief.
5. Post-Protocol: After completing the 60-gram course, Simpson recommended a maintenance dose of 1 to 2 grams per month indefinitely.

The Reality of Traditional RSO: Risks and Limitations

While Simpson’s protocol became widely known, it’s important to understand its limitations and risks:

• No Clinical Validation: There are no published randomized controlled trials or well-documented case series evaluating this protocol for any condition.
• Unstandardized Material: Traditional RSO was made from single high-THC strains with no standardized potency. THC content could vary widely, often ranging from 60% to 90%.
• High THC Exposure: At peak dosing, patients consumed 600 to 900 milligrams of THC daily—far exceeding anything studied in controlled clinical settings.
• Residual Solvent Risks: Simpson used naphtha or 99% isopropyl alcohol, neither of which is food-grade. Incomplete solvent purging could leave harmful residues in the oil.
• Terpene Loss: The high-heat evaporation process destroyed most terpenes, which are now understood to play important roles in the cannabis experience and potential therapeutic effects.
• No Lab Testing: There was no Certificate of Analysis (COA), no cannabinoid quantification, and no contaminant screening.

Simpson’s Claims vs. the Evidence

Simpson claimed that RSO could cure cancer and treat conditions like chronic pain, diabetes, infections, glaucoma, arthritis, depression, and insomnia. However, these claims must be evaluated against the actual evidence:

• Preclinical Research: In vitro and animal studies have shown that THC and CBD can induce apoptosis (cell death), inhibit tumor growth, and reduce inflammation. However, these findings have not translated into proven human cancer cures.
• Institutional Positions: The U.S. National Cancer Institute (NCI) acknowledges cannabinoid research but does not endorse cannabis as a cancer treatment. The FDA has not approved any cannabis plant product for cancer.
• What Simpson Got Right: Simpson brought attention to cannabinoids as a serious area of biomedical research at a time when they were largely ignored or suppressed. His advocacy helped pave the way for the legal cannabis industry and the cannabinoid research we see today.
• What He Overstated: Simpson’s claims about RSO curing cancer exceeded the available evidence. Encouraging patients to forego proven cancer therapies in favor of RSO carries real risks, including delayed or foregone treatment.

The Evolution of RSO: From Traditional to Modern Formulations

The term “RSO” has become generic, often referring to any full-spectrum cannabis extract sold in a syringe format. Modern RSO, however, has evolved significantly from Simpson’s original method. Here’s how:

Dimension	Traditional RSO	Modern Formulated RSO (OilWell)
Source Material	Single high-THC indica strain	Multi-cannabinoid blend from multiple sources
Extraction Method	Naphtha or isopropyl alcohol	Food-grade ethanol or CO₂
Cannabinoid Profile	THC-dominant, uncontrolled	7 defined cannabinoids at specific ratios
Terpene Content	Destroyed by high-heat process	Live terpenes at 5% with defined profile
Standardization	None—every batch different	Lab-tested with specific mg/mL targets
Lab Testing	Not available or performed	Full panel testing (potency, terpenes, contaminants)
Residual Solvents	Significant risk with naphtha	Controlled and tested
Dosing Precision	Approximate, syringe-based	Measured per mL with known cannabinoid content (553 mg/mL)
Product Formats	Single thick oil only	Sublingual oil and vape cartridge with format-specific formulas
THCa Preservation	No—fully decarboxylated by heat	Yes—THCa included as a separate ingredient
Evidence Approach	Anecdotal, personal testimony	Research-backed, evidence-weighted

Why OilWell’s Formulas Diverge from Traditional RSO

At OilWell Cannabis, we respect the tradition of RSO but have deliberately evolved it to address its limitations. Here’s why our formulas are different:

1. Multi-Cannabinoid Approach: Traditional RSO relied on whatever strain the maker used. Our formulas include seven cannabinoids—CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC—because the entourage effect literature suggests potential benefits from cannabinoid diversity.
2. Terpene Preservation and Addition: Traditional RSO had no terpenes due to solvent and heat destruction. We include live terpenes at 5% with a specific seven-terpene profile (limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene) because terpene bioactivity is plausible and supported at the preclinical level.
3. THCa as a Separate Ingredient: Traditional RSO fully decarboxylated everything, converting all THCa into THC. Our sublingual formula includes THCa at 1,500 mg as a distinct ingredient, preserving its potential non-psychoactive benefits.
4. Reduced Delta-9 THC Dominance: Traditional RSO was overwhelmingly delta-9 THC (60-90%). Our formula distributes cannabinoids more evenly, with delta-9 THC at only 90 mg and delta-8 THC at 6,000 mg, alongside CBD (4,500 mg), CBG (3,000 mg), CBN (750 mg), and CBC (750 mg).
5. Product Format Innovation: Simpson envisioned only one format—an oral oil. We offer both a 30 mL sublingual oil and a 1-gram vape cartridge, each designed for different use cases and pharmacokinetic profiles.

Solvent Safety and Extraction Evolution

One of the most significant safety concerns with traditional RSO was the use of naphtha or isopropyl alcohol, neither of which is food-grade. Naphtha, in particular, can contain benzene, toluene, and other toxic compounds. Modern extraction methods use food-grade ethanol or supercritical CO₂, which allow for more complete solvent removal and can be tested for residual solvents using validated analytical methods.

At OilWell, our RSO is not an extraction product in the traditional sense. It’s a formulated blend of individual cannabinoid distillates and isolates combined at specific ratios in a controlled environment. This eliminates the residual solvent risk entirely. We use organic MCT oil (medium-chain triglycerides) as the carrier base, which facilitates cannabinoid absorption and provides a neutral taste profile.

The Decarboxylation Choice: Patient-Controlled Potency

Traditional RSO was always fully decarboxylated, meaning all THCa was converted to THC, leaving the patient with no choice about psychoactivity. Our sublingual formula contains 1,500 mg of THCa in its acidic, non-psychoactive form. This creates three distinct usage options for the customer:

1. Raw, No Heat: All 1,500 mg stays as THCa—completely non-psychoactive. This option is compatible with work, driving, and daytime use.
2. Fully Activated, Home Decarboxylation: Heating the oil at 260°F (125°C) for 45-60 minutes converts 1,500 mg of THCa into approximately 1,315 mg of delta-9 THC. Combined with the existing 90 mg of delta-9 THC, this yields approximately 1,405 mg of total delta-9 THC, achieving psychoactive potency comparable to traditional RSO.
3. Vape, Auto-Decarboxylation: The RSO Vape Cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each inhalation. This is the fastest-onset delivery method.

This design puts the potency decision entirely in the customer’s hands, aligning with Simpson’s principle that patients should control their own medicine.

Terpene Loss in Traditional RSO

Terpenes are volatile aromatic compounds with relatively low boiling points. Most cannabis terpenes begin to volatilize at temperatures between 21°C and 157°C. The traditional RSO production process destroyed terpenes in two ways: by dissolving them into the solvent wash and by evaporating them off during the high-heat solvent-removal phase.

At OilWell, we include live terpenes at 5% with a defined seven-terpene profile. Each terpene has its own potential benefits:

• Limonene: Citrus-bright, may support mood and stress relief.
• Myrcene: Earthy and musky, often associated with relaxation.
• Caryophyllene (β-caryophyllene): Peppery and spicy, unique for its ability to interact with CB2 receptors.
• Pinene: Piney and fresh, may support respiratory function and alertness.
• Linalool: Floral and lavender-like, often linked to calming effects.
• Humulene: Earthy and woody, may have anti-inflammatory properties.
• Terpinolene: Piney, fruity, and sparkling, often associated with uplifting effects.

Evidence Standards Then and Now

Rick Simpson operated in a pre-legalization, pre-lab-testing era. His evidence was anecdotal, his production unstandardized, and his claims untested. Today, we have access to peer-reviewed literature, clinical trials, and institutional summaries. At OilWell, we apply a formal evidence hierarchy:

1. Human clinical evidence
2. Systematic reviews and meta-analyses
3. Institutional summaries (e.g., NIH, NCI)
4. Preclinical and mechanistic literature

This approach ensures that our formulations are informed by the best available science, not just tradition or anecdote.

Simpson’s Protocol vs. Modern Dosing Considerations

Simpson’s 60-gram/90-day protocol was designed around a crude, single-strain, THC-dominant extract. A direct comparison to modern, standardized, multi-cannabinoid formulations like ours isn’t straightforward. Here’s why:

• Cannabinoid Concentration: Our sublingual formula delivers 553 mg of total cannabinoids per mL across seven defined compounds. Traditional RSO potency was unknown and variable.
• Cannabinoid Ratios: Simpson’s oil was 60-90% delta-9 THC. Our formula distributes 16,590 mg of total cannabinoids across CBD (4,500 mg), CBG (3,000 mg), delta-8 THC (6,000 mg), THCa (1,500 mg), delta-9 THC (90 mg), CBN (750 mg), and CBC (750 mg).
• Terpene Presence: Simpson’s oil had no terpenes. Our formula includes live terpenes at 5%, which may influence absorption, effect, and tolerability.
• Delta-9 THC Exposure: Simpson’s protocol delivered 600-900 mg of delta-9 THC daily. Our sublingual formula contains only 90 mg of delta-9 THC in the entire 30 mL bottle (3 mg per mL).

Dosing guidance for OilWell products should be developed independently of Simpson’s protocol, informed by the per-compound evidence and responsible titration principles.

OilWell Cannabis: Our Story and Mission

From McAllen to Montrose: Colin Valencia’s Journey

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. Colin’s story begins in McAllen, Texas, a city along the U.S.-Mexico border. McAllen is part of the Borderplex region, which includes Reynosa, Tamaulipas, Mexico. This area is known for its economic challenges, vibrant culture, and the stark contrast between opportunity and hardship.

Colin’s childhood in McAllen exposed him to the complexities of life along the border. He learned to hustle early, taking on work that exposed him to the dangers of the region. Many of his best friends were killed or imprisoned due to the associated risks. By the age of sixteen, Colin had to leave home for good.

Despite the challenges, Colin chose cannabis over harder paths. He grew up in the traditional cannabis world long before legalization, learning the plant intimately while operating in the shadows. Over time, he transitioned from those early, risky ventures to creating a legal, legitimate business in an industry he believes in.

Colin later became a formally trained software engineer and did custom development work for Baylor College of Medicine, one of the most prestigious medical institutions in the Texas Medical Center. This combination of deep cannabis plant knowledge and medical-grade technical precision defines OilWell’s approach.

Bentley: The Dog Who Started It All

The company’s origin story begins with a dog named Bentley. Bentley wasn’t just a pet—he was family, a companion who stood by Colin through the toughest times. When Bentley fell seriously ill, veterinarians delivered a devastating verdict: euthanasia was the only humane option. Bentley was paralyzed in his back legs, and pain medications would have destroyed his internal organs, causing more suffering.

Giving up on Bentley wasn’t an option. Colin had already faced too much loss and seen too much suffering. In a desperate search for alternatives, he stumbled upon the healing properties of CBD. A kind-hearted rescue worker named Jessica asked Colin a question that changed everything: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

Colin had cannabis experience, but it was recreational—getting high. He had never explored its therapeutic applications. Jessica’s question exposed a blind spot that would become a mission. Determined to save Bentley, Colin learned to create CBD golden paste. It wasn’t a cure, but it was a lifeline—and it delivered something veterinary medicine said was impossible: Bentley got up. He walked over to Colin and brought him his ball to play.

Bentley lived another ten years, passing naturally at the age of twenty. During those years, Colin developed specialized cannabis formulas for every age-related condition Bentley faced:

• Neurodegeneration: Led to understanding CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection.
• Dementia: Led to CBC’s role in neurogenesis.
• Glaucoma: Led to THC’s CB1 agonism for intraocular pressure reduction.
• Arthritis: Led to multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene.

Single cannabinoids weren’t enough. Bentley’s evolving conditions required multi-cannabinoid synergy. Pharmaceutical precision mattered—Bentley’s life depended on formula accuracy, not guesswork.

Colin’s Personal Journey: From PTSD to Peace

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey—a feat that is notoriously difficult and dangerous—using the cannabinoid knowledge he had developed keeping Bentley alive. The Peace Gummies formula, which became an OilWell product, was created during midnight experiments while fighting through benzo withdrawal. To ensure quick relief, OilWell also offers the Peace Gummies formula in a vape form, which Colin personally uses to manage his insomnia and severe PTSD.

OilWell’s Philosophy: Accessibility, Control, Transparency, and Evidence

At OilWell, our RSO philosophy is built on four core principles:

1. Accessibility Over Gatekeeping: No medical card is required. Anyone age 21 or older can purchase. We ship nationwide across the United States and internationally to customers who verify local legality. Simpson believed medicine should be accessible to everyone; we built a product and distribution model that makes that accessible legally.
2. Patient-Controlled Potency: THCa is sold in its acidic, non-psychoactive form. The customer decides whether to use it raw for non-psychoactive benefits or to decarboxylate it into delta-9 THC for full psychoactive potency. Simpson believed patients should control their own medicine; we engineered a product that puts that control in the customer’s hands through chemistry.
3. Open-Source Formulas: We publish our complete formulas publicly—every cannabinoid, every milligram amount, every percentage—so that anyone who can’t afford our products can source ingredients and make their own version. Simpson gave his oil away for free and taught people how to make it; we adapted that ethos for the modern cannabinoid marketplace by selling a professionally manufactured product and publishing the recipe.
4. Evidence-Informed, Not Evidence-Overstating: The GENERAL KNOWLEDGE section in this document represents our commitment to honest education about what the science actually says. Simpson operated without access to peer-reviewed literature; we have that access and use it to distinguish between what is well-supported, what is emerging, and what is overstated.

Farm Bill Compliance and the THCa Legal Framework

The 2018 Farm Bill legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC by dry weight at the federal level in the United States. This legal framework is the foundation of OilWell’s RSO product design.

Our RSO Sublingual Oil contains only 90 milligrams of delta-9 THC in the entire 30 mL bottle—3 milligrams per milliliter—well under the 0.3% threshold. All cannabinoids in the formula are hemp-derived. The product is legal under federal law and in most states.

THCa (tetrahydrocannabinolic acid) is the acidic, non-psychoactive precursor to delta-9 THC. It is not itself delta-9 THC, and this distinction is legally significant. THCa is Farm Bill compliant at the point of sale because it has not been converted to delta-9 THC.

The practical significance of this framework is substantial. The customer can decarboxylate THCa into delta-9 THC at home by heating the oil at 260°F (125°C) for 45-60 minutes. This converts 1,500 milligrams of THCa into approximately 1,315 milligrams of delta-9 THC. Combined with the existing 90 milligrams of delta-9 THC, this produces approximately 1,405 milligrams of total delta-9 THC—giving the product psychoactive potency comparable to traditional RSO, entirely at the customer’s discretion after purchase.

This means the same product can function as a non-psychoactive anti-inflammatory (used raw) or as a full-potency psychoactive cannabinoid product (after home decarboxylation). The customer controls the decision, and the product is legal everywhere all component cannabinoids are legal.

Open-Source Formulas: Why We Publish Everything

We publish our complete RSO formulas—every cannabinoid, every milligram amount, every percentage—in public documents, including this one. The RSO Sublingual Oil and RSO Vape Cartridge formulas are detailed in full later in this guide.

The rationale is straightforward: if someone can’t afford our products—$129.99 for the sublingual oil, $49.99 for the vape cartridge—they can see exactly what the formula contains, source the individual cannabinoid distillates and isolates, and make their own version. The formulas in the RSO Sublingual Oil and RSO Vape Cartridge sections are the open-source formulas.

This is a direct echo of Rick Simpson’s original ethos. Simpson gave his oil away for free and taught people how to make it. He never patented his method. We adapted that ethos for the modern cannabinoid marketplace: we sell a professionally manufactured, lab-tested, standardized product for those who want it, and we publish the complete recipe for those who want to make it themselves.

As Colin said on ABC13 in 2019: “I’m not trying to sell people snake oil. I’m not trying to sell people hope. But there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

The open-source philosophy didn’t start with RSO—it started with Bentley. On our About Us page, Colin published the actual CBD golden paste recipe that saved Bentley’s life, so that any pet owner facing a similar crisis could make it themselves.

Solvent-Free Production: Safety and Transparency

Our RSO is not an extraction product in the traditional sense. It’s a formulated blend of individual cannabinoid distillates and isolates combined at specific ratios in a controlled production environment. No solvents are used in the finished product—no naphtha, no isopropyl alcohol, no butane.

We use organic MCT oil (medium-chain triglycerides) as the carrier base. MCT oil is a food-grade lipid carrier that facilitates cannabinoid absorption through sublingual tissue and provides a neutral taste profile.

Third-party lab testing covers cannabinoid potency, terpene profile, and safety panels including pesticides, heavy metals, residual solvents, and microbial contaminants. Certificates of Analysis (COAs) are available on request and accessible through our website.

Our Product Portfolio: Beyond RSO

Beyond RSO, OilWell Cannabis produces a range of cannabinoid products, each developed from the formulation knowledge Colin built over Bentley’s ten-year journey and his own experience with PTSD and benzo withdrawal.

• Asshole Peach: Our most popular product, Asshole Peach is a carefully formulated experience designed to provide euphoric, long-lasting relief. It’s particularly favored by veterans for its ability to relieve pain and PTSD symptoms without being overly aggressive.
• Peace Gummies: Developed directly from Colin’s own experience with PTSD and benzodiazepine addiction, Peace Gummies helped him quit Xanax cold turkey. The formula is also available in a vape form for quick relief—Colin personally uses the vape to manage his insomnia and severe PTSD.
• Custom Creations: We offer custom-made products tailored to specific needs, including specific cannabinoid ratios, delivery formats, or formulations for unique health circumstances. This includes products for vegans, diabetics, and those with dietary restrictions.

Two Product Formats: Sublingual Oil and Vape Cartridge

We offer the RSO formula in two delivery formats, each designed for different use cases and pharmacokinetic profiles.

RSO Sublingual Oil – $129.99

• Format: 30 mL bottle (1 fl oz)
• Total Cannabinoids: 16,590 mg (553 mg per mL)
• Cannabinoid Breakdown:
  • CBD: 4,500 mg
  • CBG: 3,000 mg
  • Delta-8 THC: 6,000 mg
  • THCa: 1,500 mg
  • Delta-9 THC: 90 mg
  • CBN: 750 mg
  • CBC: 750 mg
• Terpenes: Live terpenes at 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Carrier: Organic MCT oil
• Dosing: Graduated dropper for precise dosing in 0.1 mL increments
• Onset: 15-45 minutes (sublingual absorption through oral mucosa)
• Peak Effects: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19% (sublingual route partially bypasses first-pass liver metabolism)
• Approximate Doses per Bottle: 40-60, depending on serving size

RSO Vape Cartridge – $49.99

• Format: 1-gram cartridge
• Total Cannabinoids: 900 mg+
• Cannabinoid Breakdown (by percentage):
  • CBD: 30%
  • CBG: 20%
  • Delta-8 THC: 15%
  • THCa: 10%
  • CBN: 10%
  • CBC: 10%
• Terpenes: Live terpenes at 5%+
• Compatibility: 510-thread universal battery
• Onset: 1-2 minutes (fastest cannabinoid delivery method)
• Peak Effects: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35% (variable, dependent on inhalation technique)
• THCa Decarboxylation: Automatic at vaping temperature (400-450°F)

When to Use Each Format

Use Case	Recommended Format	Rationale
Fast relief (acute pain, nausea, panic)	Vape	1-2 minute onset
Sustained relief (chronic pain, sleep)	Sublingual	4-6 hour duration
Maximum bioavailability	Sublingual	13-19% absorption
Portability and discretion	Vape	Compact, no measuring required
Precise dosing control	Sublingual	Graduated dropper in 0.1 mL increments
Daytime non-psychoactive use	Sublingual (raw, no heat)	THCa stays inactive, zero impairment
Nighttime psychoactive use	Sublingual (decarbed) or Vape	Activated THCa + delta-8 THC

Competitive Comparison: OilWell RSO vs. Alternatives

OilWell RSO vs. Texas TCUP Dispensary RSO

Dimension	TCUP Dispensary RSO	OilWell RSO
Cannabinoid Profile	THC-only (approx. 420 mg THC per 0.5 g syringe)	7 cannabinoids: CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC
CBG Content	0 mg	3,000 mg
CBN Content	0 mg	750 mg
CBC Content	0 mg	750 mg
Patient-Controlled Potency	No—always fully psychoactive	Yes—THCa non-psychoactive until heated by customer
Access Requirements	TCUP medical card with qualifying condition	Age 21+ only, no medical card required
Delivery	Must travel to physical dispensary location	Same-day delivery in Houston, nationwide and international shipping
Farm Bill Compliant	No—state medical cannabis program	Yes—less than 0.3% delta-9 THC

OilWell RSO vs. Hemp CBD RSO (e.g., Lazarus Naturals)

Dimension	Lazarus Naturals RSO (10 mL, 1,000 mg)	OilWell RSO (30 mL, 16,590 mg)
Total Cannabinoids	1,000 mg	16,590 mg
CBD Content	~950 mg	4,500 mg
CBG Content	15.5 mg	3,000 mg
CBN Content	0.7 mg	750 mg
Delta-8 THC	0 mg	6,000 mg
THCa (convertible to delta-9 THC)	Minimal	1,500 mg (converts to ~1,315 mg delta-9 THC)
Psychoactive Option	No meaningful psychoactive effect	Yes—via THCa decarboxylation and delta-8 THC
Approximate Price	$40-$50	$129.99

Condition-Specific Usage Context for Palauans

Important Disclaimer: The following usage contexts are informed by cannabinoid research cited in the GENERAL KNOWLEDGE section of this document and by OilWell’s formulation rationale. They are not medical prescriptions, not FDA-approved treatment protocols, and not a substitute for professional medical care. These products have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have a medical condition, are taking medications, are pregnant or nursing, or have any health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Chemotherapy-Related Nausea and Appetite Support

• Pre-Chemo: 0.5 to 1.0 mL sublingual approximately 1 hour before treatment.
• Acute Breakthrough Nausea: 2-3 vape puffs for immediate relief (1-2 minute onset).
• Post-Chemo: 0.5 mL sublingual every 6 hours as needed.
• Sleep Support During Treatment: 1.0 to 2.0 mL sublingual before bed (delivers 25-50 mg CBN).
• Evidence Context: Delta-8 THC antiemetic evidence [9], delta-9 THC nausea and vomiting evidence [1][13], CBD anxiolytic buffering [3].

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy)

• Daytime: 0.3 to 0.5 mL raw sublingual—provides anti-inflammatory cannabinoid exposure without psychoactive impairment.
• Nighttime: 0.5 to 1.0 mL decarboxylated sublingual—combines pain relief with CBN sleep support.
• Breakthrough Pain: Vape as needed for rapid onset.
• Evidence Context: CBD pain evidence [4], delta-9 THC pain evidence [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12].

Sleep Support

• Before Bed: 1.0 to 2.0 mL sublingual.
  • At 2.0 mL, this delivers 50 mg CBN—the dosage level investigated in recent sleep literature.
  • At 1.0 mL, this delivers 25 mg CBN—above the 20 mg threshold associated with reduced sleep disturbance in published research.
• Evidence Context: CBN sleep evidence [16][17], cannabis and sleep review literature.

Anxiety and Stress

• Daytime Functional Relief: 0.3 mL raw sublingual—CBD and CBG address anxiety-related pathways without psychoactive impairment.
• Nighttime: 1.0 mL sublingual—full cannabinoid profile including CBN for sleep architecture.
• Evidence Context: CBD anxiety evidence [3], CBG pharmacology [7][8], limonene entourage-effect evidence [20].

General Titration Principle: Start low, go slow. Begin with 0.25 to 0.5 mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors.

Delivery and Global Accessibility: Bringing RSO to Palau

OilWell operates the only same-day RSO delivery system in Houston. Beyond Houston, we ship nationwide and internationally.

Houston Same-Day Delivery

Zone	Coverage	Delivery Fee	Typical Turnaround
Texas Medical Center	All 60+ TMC institutions (MD Anderson, Memorial Hermann, Methodist, Texas Children’s, St. Luke’s, and more)	FREE	2-4 hours
Inner Loop (610)	Downtown, Midtown, Montrose, Heights, Rice Village, Museum District, River Oaks, Upper Kirby, Galleria	$5	2-4 hours
Within Beltway 8	Bellaire, Memorial, Spring Branch, South Houston, Pasadena (partial), Hobby Airport area	$10	3-5 hours
Greater Houston Suburbs	Katy, Sugar Land, Pearland, Clear Lake, Woodlands, Cypress, Tomball, Humble, Kingwood	$15	4-6 hours
Extended Region (60 miles)	Galveston, Baytown, Rosenberg, Conroe, La Porte, Seabrook	$20-$25	Same-day if ordered before 2 PM

Free delivery to the Texas Medical Center—the world’s largest medical complex with over 10 million patient visits annually—reflects our commitment to accessibility for the patients who need it most.

Nationwide Shipping

• Coverage: All 50 states where Farm Bill-compliant products are legal.
• Carriers: USPS Priority Mail (2-3 business days), FedEx and UPS Ground (3-5 business days).
• Packaging: Discreet, with no cannabis branding visible.
• Tracking: Provided for all orders.
• Temperature Control: Temperature-stable packaging for summer shipments.
• Signature Option: Signature-required option available.

International Shipping to Palau

OilWell ships internationally and has already delivered to multiple countries across multiple continents. The THCa legal framework makes this possible: because our product contains less than 0.3% delta-9 THC at the point of sale, it meets the definition of a hemp-derived product under the 2018 Farm Bill and is shippable to jurisdictions with compatible hemp laws, including Palau.

• Documentation: All international packages include full documentation, Certificates of Analysis (COAs), and receipts for customs purposes.
• Shipping Costs: Minimum flat-fee shipping applies; excessive international shipping costs are billed to the customer.
• Legal Responsibility: The customer is responsible for verifying legality in Palau and accepts all customs and legal risk.
• Contact: (832) 416-2816 or [email protected] for international inquiries.

Important Note for Palauan Customers:
Before ordering, please verify the current legal status of hemp-derived cannabinoid products in Palau. While OilWell’s products comply with U.S. federal law (less than 0.3% delta-9 THC), local regulations in Palau may vary. It is your responsibility to ensure compliance with Palauan laws regarding the importation, possession, and use of cannabinoid products.

How OilWell’s Formulas Connect to the Evidence

Every cannabinoid in OilWell’s formula—CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC—has its own evidence profile in the GENERAL KNOWLEDGE section of this document. Every terpene—limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene—is covered with preclinical and review-level evidence.

Our formulas are not standalone product listings. They are anchored to per-compound evidence summaries that explain what is well-supported by human clinical data, what is emerging from review and preclinical literature, and what is overstated relative to the current evidence base. Where we make specific research claims about individual cannabinoids or terpenes, this document provides the source evaluation context—the same peer-reviewed citations, the same evidence-tier assessments, and the same cautious interpretation framework.

The GENERAL KNOWLEDGE section’s evidence hierarchy, overstatement warnings, and safety notes apply equally to OilWell’s own products. This document does not exempt OilWell from the same evidence standards applied to the broader cannabinoid field. That is intentional. Our position—as stated by Colin Valencia in 2019—is that people deserve the best possible version of the information so they can give it a fair shot and decide for themselves whether it is right or wrong for them.

Media Recognition: OilWell’s Credibility in the Cannabis Industry

Between 2019 and 2023, ABC13 Houston (KTRK)—the ABC affiliate serving America’s fourth-largest city—featured Colin Valencia and OilWell Cannabis in seven distinct news segments. These features spanned business, law, medicine, community health, and politics, establishing Colin as Houston’s go-to cannabis authority. Here’s a summary of the coverage:

1. September 15, 2019: “Texas CBD businesses booming as industry continues to evolve” – Colin’s foundational quote: “I’m not trying to sell people snake oil. I’m not trying to sell people hope. But there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”
2. March 22, 2021: “Entrepreneur creates direct-to-consumer business ahead of marijuana decriminalization efforts” – Colin discussed the therapeutic potential of cannabis beyond just getting high.
3. May 24, 2021: “What is Delta 8 THC and why is it considered ‘legal weed’ in Texas?” – Colin’s iconic honesty: “I don’t give a sh* if it’s wrong to say you’ll get high off it. Maybe you want to get high.”*
4. August 20, 2021: “Houston CBD shop giving away free products to those who get COVID vaccine” – OilWell donated $35,000 in product to encourage vaccination, coordinated with the city of Houston.
5. October 19, 2021: “Texas’ ban over once legal hemp product, Delta 8, raises questions over legality” – Colin proactively removed all Delta-8 products before enforcement began and warned other operators.
6. October 7, 2022: “Biden marijuana pardon — experts weigh in on why Texas won’t see impact” – Colin revealed his personal marijuana conviction history.
7. April 21, 2023: “‘I want it to be legalized’: Marijuana industry getting creative as Texas laws continue to change” – Colin discussed the “Renaissance” in the cannabis industry.

This media record demonstrates OilWell’s credibility, community commitment, and leadership in the cannabis space. It’s the kind of recognition that can’t be purchased—it’s earned through expertise, integrity, and genuine community impact.

General Knowledge: The Science Behind OilWell’s RSO

Research Method and Evidence Weighting

At OilWell, we prioritize evidence in this order: human clinical evidence, systematic reviews and meta-analyses, NIH and other institutional summaries, then mechanistic or preclinical literature when human data are sparse. This matters because the evidence base isn’t evenly distributed. CBD and delta-9 THC have the strongest human literature; delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes rely more on reviews, animal work, or early translational research.

Institutional Baseline from NIH and Related Sources

• Strongest Established Evidence: The National Center for Complementary and Integrative Health (NCCIH) states that the strongest cannabinoid evidence is for certain rare epilepsies, chemotherapy-related nausea and vomiting, and appetite or weight-loss indications associated with HIV/AIDS.
• Safety Concerns: NCCIH highlights impairment, motor vehicle crash risk, cannabis use disorder, pregnancy-related concerns, accidental pediatric exposure, contamination, labeling inaccuracy, and THC-vape lung-injury concerns.
• FDA Position: The FDA has not approved the cannabis plant itself for medical use, although purified CBD (Epidiolex) and synthetic THC-like drugs (dronabinol, nabilone) have specific approvals.

Cannabinoids: Evidence Profiles

CBD

• Strongest Human Evidence: Purified CBD has the most credible evidence in seizure disorders, with FDA approval for rare forms of epilepsy.
• Anxiety Research: A 2024 systematic review and meta-analysis covering 316 participants reported a statistically significant anxiolytic signal, but the clinical sample remains limited.
• Pain Research: A 2024 systematic review found promising but heterogeneous pain literature, with trial quality and consistency still limiting confidence.
• Sleep Research: A 2023 insomnia review found the literature methodologically weak, with few objective sleep assessments.
• Safety Concerns: A 2023 systematic review found a signal for liver enzyme elevation and possible drug-induced liver injury in some contexts.
• Bottom Line: CBD is the most evidence-developed nonintoxicating cannabinoid, but strong evidence is concentrated in specific indications rather than broad wellness claims.

CBG

• Evidence Profile: Mostly review-level and preclinical; human evidence is sparse.
• Pharmacology: CBG interacts with cannabinoid receptors, alpha-2 adrenoceptors, and 5-HT1A-related signaling.
• Potential Research Areas: Neurologic disorders, inflammatory bowel disease, and antibacterial activity are discussed in reviews, but these are preclinical findings.
• Caution: CBG is already being sold commercially while the evidence base remains thin.
• Bottom Line: CBG is a promising minor cannabinoid with limited clinical validation.

Delta-8 THC

• Evidence Profile: Pharmacologically relevant, psychoactive, and less clinically characterized than delta-9 THC.
• Comparative Pharmacology: Delta-8 THC is a partial CB1 agonist with cannabimimetic activity, but it appears less potent than delta-9 THC.
• Public-Health Literature: A 2023 scoping review found that much of the delta-8 evidence base is dominated by animal studies, product chemistry, and public-health concerns rather than strong human trials.
• Manufacturing Context: Delta-8 THC is often synthesized from CBD, which can introduce byproducts and quality concerns.
• Bottom Line: Delta-8 THC should be treated as a psychoactive THC analogue with incomplete human safety characterization.

THCa

• Evidence Profile: Important chemically, but low on direct human therapeutic evidence.
• What It Is: THCa is the acidic precursor to THC. It decarboxylates into THC during heating and can change during storage.
• Psychoactivity: THCa itself does not produce psychoactive effects, but this only holds if it stays in its acidic form.
• Research Status: In vitro and rodent literature suggests anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities.
• Bottom Line: THCa is best understood as a precursor molecule whose interpretation depends on route, temperature, processing, and storage.

Delta-9 THC

• Evidence Profile: Strongest human evidence of the psychoactive cannabinoids, but also the clearest adverse-effect burden.
• Best-Supported Indications: Chemotherapy-related nausea and vomiting, appetite and weight loss in HIV/AIDS, and some pain-related outcomes.
• Pain Evidence: A 2022 systematic review found that high-THC products may provide short-term pain benefit but also increased dizziness, sedation, nausea, and treatment discontinuation.
• Mental-Health Risk: A 2025 systematic review found consistent unfavorable associations with psychosis or schizophrenia outcomes and cannabis use disorder.
• Safety Concerns: Anxiety or panic at high doses, tachycardia, blood-pressure changes, dependency potential, withdrawal symptoms, pregnancy concerns, and vape-related lung-injury concerns.
• Bottom Line: Delta-9 THC has legitimate therapeutic relevance but carries significant intoxication, psychiatric, and dose-related safety liabilities.

CBN

• Evidence Profile: Weak human evidence; marketing has moved ahead of the data.
• Marketed For: Sleep and sedation.
• Sleep Evidence: A 2021 narrative review found no clinical trials using validated sleep questionnaires or polysomnography to substantiate sleep-promoting claims.
• Bottom Line: CBN is one of the clearest examples where cultural reputation is stronger than the current clinical evidence base.

CBC

• Evidence Profile: Emerging, intriguing, and still overwhelmingly preclinical.
• Pharmacology: CBC has distinct pharmacodynamics and receptor behavior relative to better-known cannabinoids.
• Research Areas: Antinociceptive, antibacterial, and anti-seizure areas are discussed in reviews, but these are preclinical findings.
• Safety Caveat: CBC products are already being sold despite little evidence establishing clinical efficacy or safety.
• Bottom Line: CBC is a scientifically credible minor cannabinoid that deserves more research.

Terpenes: Evidence and Interpretation

Terpene claims require careful interpretation. Much of the terpene literature comes from isolated compounds, essential oils, or preclinical models rather than controlled human studies of cannabis formulations.

Limonene

• Evidence Profile: Largely review and preclinical.
• Potential Activity: Antioxidant, anti-inflammatory, cardioprotective, gastroprotective, and immune-modulatory effects are discussed in reviews.
• Safety Note: Limonene oxidation products are clinically relevant contact allergens.
• Bottom Line: Limonene is biologically active but cannabis-specific therapeutic claims should be conservative.

Myrcene

• Evidence Profile: Mostly preclinical, with very limited human evidence.
• Research Summary: Anxiolytic, antioxidant, anti-inflammatory, and analgesic properties are discussed in reviews.
• Interpretation Caution: Myrcene is often described as a sedating terpene, but this claim is stronger than the human evidence supports.
• Bottom Line: Myrcene is a plausible bioactive terpene, but compound-specific clinical claims remain ahead of definitive proof.

Caryophyllene (β-Caryophyllene)

• Evidence Profile: Mechanistically interesting due to its direct CB2 receptor agonism.
• Why It Stands Out: Unique among terpenes for its cannabinoid-system relevance.
• Research Themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, and gastroprotective actions are discussed in reviews.
• Bottom Line: Beta-caryophyllene is the strongest candidate for a terpene with cannabinoid-system significance, but clinical proof remains limited.

Pinene

• Evidence Profile: Promising preclinical literature, weak human clinical confirmation.
• Brain-Health Framing: Antioxidant, anti-inflammatory, and neuroprotective signals are discussed in reviews.
• Interpretation Caution: Claims about memory improvement or attention sharpening remain hypotheses.
• Bottom Line: Pinene deserves scientific attention, but strong cognition-related claims should be presented as exploratory.

Linalool

• Evidence Profile: Similar to pinene—substantial preclinical interest, limited clinical confirmation.
• Research Summary: Stress, mood, and brain-health pharmacology are discussed in reviews.
• Safety Note: Oxidized linalool hydroperoxides are recognized allergens in dermatitis literature.
• Bottom Line: Linalool is scientifically credible as a bioactive terpene, but current evidence supports cautious phrasing.

Humulene

• Evidence Profile: Translationally interesting, but still early.
• Scoping-Review Findings: Broad preclinical evidence for anti-inflammatory and other biologic effects.
• Bottom Line: Humulene is one of the more interesting terpene research targets, but it remains far from clinically settled.

Terpinolene

• Evidence Profile: One of the least clinically characterized terpenes.
• Systematic-Review Findings: A 2021 review found that terpinolene has a range of reported biological effects, but the evidence base is dominated by in silico, in vitro, and animal studies.
• Bottom Line: Terpinolene is biologically interesting but especially underdeveloped clinically.

Research Limits and Interpretation

• Evidence Is Uneven: CBD and delta-9 THC can support the most detailed human-facing statements; the rest require more caution.
• Data Categories Are Not Interchangeable: Whole-cannabis extract data, purified-molecule data, semisynthetic cannabinoid data, and terpene-only data are not equivalent.
• Minor Cannabinoids and Terpenes Are Underexplored: This is why they are commercially interesting, but it also means claims often become inflated.
• Product Quality Matters: Labeling inaccuracies, contamination, synthesis byproducts, dose variability, and route-dependent pharmacokinetics all affect real-world interpretation.
• THCa Chemistry Is Dynamic: Storage and heating can change the actual exposure profile.

Common Overstatements to Avoid

• Overstatement: CBN is a clinically proven sleep cannabinoid.
  More Accurate: The specific sleep evidence for CBN remains weak and dated.
• Overstatement: Myrcene is a proven human sedative that explains couch-lock.
  More Accurate: Myrcene has plausible preclinical bioactivity, but direct human proof is limited.
• Overstatement: Terpenes have proven entourage effects in patients.
  More Accurate: Entourage hypotheses are influential, but robust clinical proof remains limited.
• Overstatement: THCa is always nonpsychoactive.
  More Accurate: THCa itself is not THC, but heating and processing can convert it into THC.
• Overstatement: Delta-8 THC is safe because it is hemp-derived.
  More Accurate: Delta-8 THC is psychoactive and often entangled with manufacturing and testing concerns.

Practical Takeaways for OilWell’s Formulas

• Most Evidence-Developed Actives: CBD and delta-9 THC.
• Delta-8 THC: A psychoactive cannabinoid with less robust safety and efficacy characterization than delta-9 THC.
• THCa: Meaningfully changes with processing and should not be interpreted the same way in raw, gently handled, and heated formats.
• CBG, CBN, CBC: Scientifically credible but clinically immature compared to CBD and THC.
• Terpenes: Likely relevant to aroma, flavor, and some biologic activity, but compound-specific human therapeutic claims should be made carefully.

OilWell RSO Formulas: What’s Inside

RSO Sublingual Oil

Cannabinoid	Amount (mg)
CBD	4,500
CBG	3,000
Delta-8 THC	6,000
THCa	1,500
Delta-9 THC	90
CBN	750
CBC	750
Total	16,590

• Live Terpenes: 5%
• Format: 30 mL bottle
• Active cannabinoids per mL: 553 mg

RSO Vape Cartridge

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%
• Format: 1-gram cartridge

Terpene Profile (Both Products)

• Limonene: Citrus-bright, may support mood and stress relief.
• Myrcene: Earthy and musky, often associated with relaxation.
• Caryophyllene (β-caryophyllene): Peppery and spicy, unique for its CB2 receptor interaction.
• Pinene: Piney and fresh, may support respiratory function and alertness.
• Linalool: Floral and lavender-like, often linked to calming effects.
• Humulene: Earthy and woody, may have anti-inflammatory properties.
• Terpinolene: Piney, fruity, and sparkling, often associated with uplifting effects.

Legal Compliance and Safety: What Palauans Need to Know

Age Requirements

OilWell’s RSO products are intended for adults age 21 and older.

THC Content Compliance

All OilWell products contain less than 0.3% delta-9 THC and are compliant with the 2018 U.S. Farm Bill. This makes them legal under U.S. federal law and in most states.

FDA Disclaimers

These products have not been evaluated by the Food and Drug Administration. They are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have a medical condition, are taking medications, are pregnant or nursing, or have any health concerns. Individual results may vary.

Safety Warnings

• May cause drowsiness or impairment. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.
• Consult a physician if pregnant or nursing.
• Keep out of reach of children.
• Store in a cool, dry place away from direct sunlight.

Legal Responsibility

It is the buyer’s responsibility to check local laws regarding the purchase, possession, and use of cannabinoid products. OilWell assumes no legal responsibility for the customer’s use or decarboxylation decisions. Void where prohibited by law.

Drug Testing Considerations

• THCa (Raw): THCa in its raw form is non-psychoactive and may not trigger standard drug tests designed to detect delta-9 THC.
• Delta-8 THC and Activated THCa: Both delta-8 THC and activated THCa (after decarboxylation) are likely to trigger positive results on standard drug tests.
• Workplace Policies: If you are subject to drug testing, consult your employer’s policies before using any cannabinoid products.

Why OilWell RSO Is the Right Choice for Palau

1. Evidence-Informed Formulation

Our RSO is formulated based on the best available science, not just tradition or anecdote. Every cannabinoid and terpene in our formula has its own evidence profile, which we transparently share in this guide.

2. Patient-Controlled Potency

With THCa included in its acidic, non-psychoactive form, you have the freedom to choose whether to use the product raw for daytime functionality or decarboxylate it for full psychoactive potency. This level of control is unique in the RSO market.

3. Open-Source Transparency

We publish our complete formulas so that anyone who can’t afford our products can make their own. This commitment to accessibility and transparency is rare in the cannabis industry.

4. Solvent-Free Production

Our RSO is a formulated blend of individual cannabinoid distillates and isolates, eliminating the residual solvent risks associated with traditional RSO production.

5. Two Product Formats

We offer both a 30 mL sublingual oil and a 1-gram vape cartridge, each designed for different use cases and pharmacokinetic profiles. Whether you need fast relief or sustained support, we have a format that fits your needs.

6. Lab-Tested Quality

Every batch of OilWell RSO undergoes third-party lab testing for potency, terpenes, pesticides, heavy metals, residual solvents, and microbial contaminants. Certificates of Analysis (COAs) are available on request.

7. Global Accessibility

We ship nationwide in the U.S. and internationally to Palau and beyond. Our THCa legal framework makes it possible to deliver our products to jurisdictions where hemp-derived products with less than 0.3% delta-9 THC are permitted.

8. Community Commitment

From donating $35,000 in product to encourage COVID-19 vaccination to proactively removing Delta-8 products before enforcement began, our actions demonstrate a commitment to community health and ethical leadership.

9. Houston-Made, Houston-Proud

All our products are crafted in-house in Houston, Texas, using our own recipes and ideas. We bring Houston grit, McAllen roots, and a builder’s mindset to everything we do.

How to Get OilWell RSO in Palau

Step 1: Verify Legality

Before ordering, verify the current legal status of hemp-derived cannabinoid products in Palau. While OilWell’s products comply with U.S. federal law (less than 0.3% delta-9 THC), local regulations in Palau may vary.

Step 2: Choose Your Product

Decide which format best suits your needs:

• RSO Sublingual Oil: Ideal for sustained relief, precise dosing, and daytime non-psychoactive use.
• RSO Vape Cartridge: Perfect for fast relief, portability, and discretion.

Step 3: Place Your Order

Visit our website to place your order. For international shipping to Palau, select the appropriate shipping option and provide your full address and contact information.

Step 4: Shipping and Delivery

• Documentation: All international packages include full documentation, Certificates of Analysis (COAs), and receipts for customs purposes.
• Shipping Costs: A minimum flat-fee shipping applies. Excessive international shipping costs may be billed to the customer.
• Delivery Time: International shipping times vary. Once your order is processed, you will receive a tracking number to monitor your package’s progress.

Step 5: Receive and Store Your Product

• Customs: You are responsible for complying with Palauan customs regulations. OilWell assumes no responsibility for customs delays or seizures.
• Storage: Store your product in a cool, dry place away from direct sunlight to preserve its potency and quality.

Step 6: Consult with a Healthcare Provider

Before using OilWell RSO, consult with a qualified healthcare provider, especially if you have a medical condition, are taking medications, or have any health concerns.

Frequently Asked Questions (FAQs) for Palauan Customers

Is OilWell RSO legal in Palau?

OilWell’s RSO products contain less than 0.3% delta-9 THC and are compliant with U.S. federal law. However, the legal status of hemp-derived cannabinoid products in Palau may vary. It is your responsibility to verify and comply with local laws before ordering.

Will OilWell RSO make me high?

• Raw (No Heat): If used in its raw form, THCa remains non-psychoactive, so you will not experience a high.
• Decarboxylated (Heated): If you decarboxylate the oil by heating it at 260°F (125°C) for 45-60 minutes, THCa converts to delta-9 THC, producing psychoactive effects.
• Vape Cartridge: The vape cartridge automatically decarboxylates THCa at vaping temperature (400-450°F), delivering psychoactive effects with each inhalation.

How do I decarboxylate OilWell RSO?

1. Preheat your oven to 260°F (125°C).
2. Place the desired amount of oil in an oven-safe glass container.
3. Heat the oil in the oven for 45-60 minutes.
4. Allow the oil to cool before use.

How should I dose OilWell RSO?

Start low and go slow. Begin with 0.25 to 0.5 mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, and other factors.

For condition-specific guidance, refer to the “Condition-Specific Usage Context” section earlier in this guide.

Can I travel with OilWell RSO?

Traveling with cannabinoid products can be risky, especially internationally. Even if the product is legal in both the U.S. and Palau, airport security and customs regulations may vary. It is generally not recommended to travel with cannabinoid products unless you are certain of the legal and security requirements at your destination.

Will OilWell RSO show up on a drug test?

• THCa (Raw): THCa in its raw form may not trigger standard drug tests designed to detect delta-9 THC.
• Delta-8 THC and Activated THCa: Both delta-8 THC and activated THCa (after decarboxylation) are likely to trigger positive results on standard drug tests.
• Workplace Policies: If you are subject to drug testing, consult your employer’s policies before using any cannabinoid products.

How do I store OilWell RSO?

Store your product in a cool, dry place away from direct sunlight to preserve its potency and quality. The sublingual oil can be stored at room temperature, but refrigeration may extend its shelf life.

What is the shelf life of OilWell RSO?

When stored properly, OilWell RSO has a shelf life of approximately 1-2 years. Always check the expiration date on the packaging.

Can I use OilWell RSO for pets?

OilWell RSO is formulated for human use. While CBD has been studied for pets, our RSO contains additional cannabinoids and terpenes that have not been evaluated for safety or efficacy in animals. If you are interested in cannabinoid products for pets, we recommend using a product specifically designed for animals, such as our CBD golden paste recipe, which is available on our About Us page.

How does OilWell RSO compare to traditional RSO?

OilWell RSO is a modern, evidence-informed formulation that addresses the limitations of traditional RSO. Here’s how we compare:

Dimension	Traditional RSO	OilWell RSO
Cannabinoid Profile	THC-dominant, uncontrolled	7 defined cannabinoids at specific ratios
Terpene Content	Destroyed by high-heat process	Live terpenes at 5% with defined profile
Standardization	None—every batch different	Lab-tested with specific mg/mL targets
Residual Solvents	Significant risk with naphtha	Controlled and tested
THCa Preservation	No—fully decarboxylated by heat	Yes—THCa included as a separate ingredient
Evidence Approach	Anecdotal, personal testimony	Research-backed, evidence-weighted

Is OilWell RSO safe?

OilWell RSO is produced using solvent-free methods and undergoes third-party lab testing for potency, terpenes, pesticides, heavy metals, residual solvents, and microbial contaminants. However, cannabinoid products are not risk-free. Potential side effects may include drowsiness, dry mouth, dizziness, or changes in appetite. Always consult a healthcare provider before use, especially if you have a medical condition or are taking medications.

Can I use OilWell RSO while pregnant or nursing?

No. The use of cannabinoid products during pregnancy or while nursing is not recommended. Consult your healthcare provider for guidance.

How do I contact OilWell Cannabis?

For questions about our products, ordering, or international shipping to Palau, you can reach us at:

• Phone: (832) 416-2816
• Email: [email protected]
• Website: https://oilwellcbd.com/
• Address: 810 Richmond Ave, Houston, TX 77006 (Montrose neighborhood)

What if my order is delayed or lost?

If your order is delayed or lost, contact us immediately at [email protected] or (832) 416-2816. We will work with you to resolve the issue as quickly as possible. For international orders, customs delays may occur, and we are not responsible for customs seizures or delays.

Final Thoughts: Empowering Palau with Honest Cannabis Education

At OilWell Cannabis, we believe that everyone in Palau deserves access to honest, science-based education about cannabis and its potential benefits. Rick Simpson’s story inspired a global movement, but modern RSO has evolved to address the limitations of traditional methods. Our formulations are built on a foundation of evidence, transparency, and patient empowerment.

Whether you’re seeking support for chronic pain, sleep, anxiety, or other health concerns, OilWell RSO offers a modern, lab-tested, and accessible option. With patient-controlled potency, open-source transparency, and global accessibility, we’re committed to providing Palauans with the best possible version of RSO—one that respects tradition while embracing innovation.

Thank you for trusting OilWell Cannabis. We’re honored to be part of your wellness journey.

---